{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:18:44Z","timestamp":1794057524896,"version":"4.8.0"},"reference-count":280,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-2023AZMETQN-0066"],"award-info":[{"award-number":["Y-2023AZMETQN-0066"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62131009"],"award-info":[{"award-number":["62131009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13402-025-01103-3","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:22:48Z","timestamp":1756214568000},"page":"1267-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The emerging role of microbiota in lung cancer: a new perspective on lung cancer development and treatment"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9646-1921","authenticated-orcid":false,"given":"Chenxi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"issue":"3","key":"1103_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"F. Bray, M. Laversanne, H. Sung et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. May-Jun. 74(3), 229\u2013263 (2024). https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"May-Jun"},{"issue":"7689","key":"1103_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"24","author":"RS Herbst","year":"2018","unstructured":"R.S. Herbst, D. Morgensztern, C. Boshoff, The biology and management of non-small cell lung cancer. Nat. Jan. 24(7689), 446\u2013454 (2018). https:\/\/doi.org\/10.1038\/nature25183","journal-title":"Nat. Jan"},{"issue":"1","key":"1103_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13059-018-1501-6","volume":"24","author":"KL Greathouse","year":"2018","unstructured":"K.L. Greathouse, J.R. White, A.J. Vargas et al., Interaction between the Microbiome and TP53 in human lung cancer. Genome Biology Aug. 24(1), 123 (2018). https:\/\/doi.org\/10.1186\/s13059-018-1501-6","journal-title":"Genome Biology Aug"},{"issue":"10","key":"1103_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"11","author":"N Cullin","year":"2021","unstructured":"N. Cullin, C. Azevedo Antunes, R. Straussman, C.K. Stein-Thoeringer, E. Elinav, Microbiome and cancer. Cancer cell. Oct. 11(10), 1317\u20131341 (2021). https:\/\/doi.org\/10.1016\/j.ccell.2021.08.006","journal-title":"Oct"},{"issue":"6494","key":"1103_CR5","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"29","author":"D Nejman","year":"2020","unstructured":"D. Nejman, I. Livyatan, G. Fuks et al., The human tumor Microbiome is composed of tumor type-specific intracellular bacteria. Sci. (New York NY) May. 29(6494), 973\u2013980 (2020). https:\/\/doi.org\/10.1126\/science.aay9189","journal-title":"Sci. (New York NY) May"},{"key":"1103_CR6","doi-asserted-by":"publisher","unstructured":"J.J. Tsay, B.G. Wu, M.H. Badri et al., Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am. J. Respir. Crit. Care Med. Nov 1. 2018;198(9):1188\u20131198. https:\/\/doi.org\/10.1164\/rccm.201710-2118OC","DOI":"10.1164\/rccm.201710-2118OC"},{"key":"1103_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-physiol-021115-105238","volume":"78","author":"RP Dickson","year":"2016","unstructured":"R.P. Dickson, J.R. Erb-Downward, F.J. Martinez, G.B. Huffnagle, The Microbiome and the respiratory tract. Annu. Rev. Physiol. 78, 481\u2013504 (2016). https:\/\/doi.org\/10.1146\/annurev-physiol-021115-105238","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"1103_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"K.F. Budden, S.L. Gellatly, D.L. Wood et al., Emerging pathogenic links between microbiota and the gut-lung axis. Nat. Reviews Microbiol. Jan. 15(1), 55\u201363 (2017). https:\/\/doi.org\/10.1038\/nrmicro.2016.142","journal-title":"Nat. Reviews Microbiol. Jan"},{"issue":"2","key":"1103_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"L. Derosa, B. Routy, A.M. Thomas et al., Intestinal Akkermansia muciniphila predicts clinical response to PD-1 Blockade in patients with advanced non-small-cell lung cancer. Nat. Med. Feb. 28(2), 315\u2013324 (2022). https:\/\/doi.org\/10.1038\/s41591-021-01655-5","journal-title":"Nat. Med. Feb"},{"issue":"7","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","volume":"16","author":"R Knight","year":"2018","unstructured":"R. Knight, A. Vrbanac, B.C. Taylor et al., Best practices for analysing microbiomes. Nat. Reviews Microbiol. Jul. 16(7), 410\u2013422 (2018). https:\/\/doi.org\/10.1038\/s41579-018-0029-9","journal-title":"Nat. Reviews Microbiol. Jul"},{"key":"1103_CR11","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-marine-120709-142811","author":"JA Gilbert","year":"2011","unstructured":"J.A. Gilbert, C.L. Dupont, Microbial metagenomics: beyond the genome. Annual Rev. Mar. Sci. (2011). https:\/\/doi.org\/10.1146\/annurev-marine-120709-142811. 3:347 \u2013 71","journal-title":"Annual Rev. Mar. Sci."},{"key":"1103_CR12","doi-asserted-by":"publisher","unstructured":"P.C. Woo, S.K. Lau, J.L. Teng, H. Tse, K.Y. Yuen, Oct. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. clinical microbiology and infection : the official publication of the European society of clinical microbiology and infectious diseases. 2008;14(10):908\u2013934. https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02070.x","DOI":"10.1111\/j.1469-0691.2008.02070.x"},{"issue":"3","key":"1103_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"B.A. Helmink, M.A.W. Khan, A. Hermann, V. Gopalakrishnan, J.A. Wargo, The microbiome, cancer, and cancer therapy. Nat. Med. Mar. 25(3), 377\u2013388 (2019). https:\/\/doi.org\/10.1038\/s41591-019-0377-7","journal-title":"Nat. Med. Mar."},{"key":"1103_CR14","doi-asserted-by":"publisher","unstructured":"W.S. Garrett, Cancer and the microbiota. Science (New York, NY). Apr 3. 2015;348(6230):80\u2009\u2013\u20096. https:\/\/doi.org\/10.1126\/science.aaa4972","DOI":"10.1126\/science.aaa4972"},{"issue":"7","key":"1103_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41571-023-00766-x","volume":"20","author":"CC Wong","year":"2023","unstructured":"C.C. Wong, J. Yu, Gut microbiota in colorectal cancer development and therapy. Nat. Reviews Clin. Oncol. Jul. 20(7), 429\u2013452 (2023). https:\/\/doi.org\/10.1038\/s41571-023-00766-x","journal-title":"Nat. Reviews Clin. Oncol. Jul"},{"issue":"1","key":"1103_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13020-023-00742-8","volume":"10","author":"LY Kong","year":"2023","unstructured":"L.Y. Kong, X.Y. Chen, X. Lu, Q. Caiyin, D.H. Yang, Association of lung-intestinal microecology and lung cancer therapy. Chin. Med. Apr. 10(1), 37 (2023). https:\/\/doi.org\/10.1186\/s13020-023-00742-8","journal-title":"Chin. Med. Apr"},{"issue":"1","key":"1103_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.24869\/psyd.2017.28","volume":"29","author":"K Latalova","year":"2017","unstructured":"K. Latalova, M. Hajda, J. Prasko, Can gut microbes play a role in mental disorders and their treatment? Psychiatria Danubina Mar. 29(1), 28\u201330 (2017). https:\/\/doi.org\/10.24869\/psyd.2017.28","journal-title":"Psychiatria Danubina Mar."},{"issue":"4","key":"1103_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/nrg3182","volume":"13","author":"I Cho","year":"2012","unstructured":"I. Cho, M.J. Blaser, The human microbiome: at the interface of health and disease. Nat. Reviews Genet. Mar. 13. 13(4), 260\u2013270 (2012). https:\/\/doi.org\/10.1038\/nrg3182","journal-title":"Nat. Reviews Genet. Mar. 13"},{"key":"1103_CR19","doi-asserted-by":"publisher","first-page":"26191","DOI":"10.3402\/mehd.v26.26191","volume":"26","author":"S Carding","year":"2015","unstructured":"S. Carding, K. Verbeke, D.T. Vipond, B.M. Corfe, L.J. Owen, Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Disease. 26, 26191 (2015). https:\/\/doi.org\/10.3402\/mehd.v26.26191","journal-title":"Microb. Ecol. Health Disease"},{"issue":"6","key":"1103_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","volume":"30","author":"D Zheng","year":"2020","unstructured":"D. Zheng, T. Liwinski, E. Elinav, Interaction between microbiota and immunity in health and disease. Cell. Res. Jun. 30(6), 492\u2013506 (2020). https:\/\/doi.org\/10.1038\/s41422-020-0332-7","journal-title":"Cell. Res. Jun"},{"key":"1103_CR21","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3389\/fimmu.2017.01678","volume":"8","author":"L Chiu","year":"2017","unstructured":"L. Chiu, T. Bazin, M.E. Truchetet, T. Schaeverbeke, L. Delhaes, T. Pradeu, Protective microbiota: from localized to Long-Reaching Co-Immunity. Front. Immunol. 8, 1678 (2017). https:\/\/doi.org\/10.3389\/fimmu.2017.01678","journal-title":"Front. Immunol."},{"key":"1103_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3369","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova A, Kurilshikov A, Bonder MJ, et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science (New York, NY). 352(6285):565-9 (Apr 29 2016) https:\/\/doi.org\/10.1126\/science.aad3369"},{"issue":"7285","key":"1103_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"4","author":"J Qin","year":"2010","unstructured":"J. Qin, R. Li, J. Raes et al., A human gut microbial gene catalogue established by metagenomic sequencing. Nat. Mar. 4(7285), 59\u201365 (2010). https:\/\/doi.org\/10.1038\/nature08821","journal-title":"Nat. Mar."},{"issue":"1","key":"1103_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-016-0181-2","volume":"4","author":"KL Ormerod","year":"2016","unstructured":"K.L. Ormerod, D.L. Wood, N. Lachner et al., Genomic characterization of the uncultured bacteroidales family S24-7 inhabiting the guts of homeothermic animals. Microbiome Jul 7. 4(1), 36 (2016). https:\/\/doi.org\/10.1186\/s40168-016-0181-2","journal-title":"Microbiome Jul 7"},{"key":"1103_CR25","doi-asserted-by":"publisher","first-page":"1170326","DOI":"10.3389\/fcimb.2023.1170326","volume":"13","author":"X Lu","year":"2023","unstructured":"X. Lu, L. Xiong, X. Zheng, Q. Yu, Y. Xiao, Y. Xie, Structure of gut microbiota and characteristics of fecal metabolites in patients with lung cancer. Front. Cell. Infect. Microbiol. 13, 1170326 (2023). https:\/\/doi.org\/10.3389\/fcimb.2023.1170326","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"1103_CR26","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.7150\/ijbs.35980","volume":"15","author":"F Liu","year":"2019","unstructured":"F. Liu, J. Li, Y. Guan et al., Dysbiosis of the gut Microbiome is associated with tumor biomarkers in lung cancer. Int. J. Biol. Sci. 15(11), 2381\u20132392 (2019). https:\/\/doi.org\/10.7150\/ijbs.35980","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"1103_CR27","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1038\/s41467-024-47273-w","volume":"8","author":"P Liu","year":"2024","unstructured":"P. Liu, Z. Liu, J. Wang et al., Immunoregulatory role of the gut microbiota in inflammatory depression. Nat. Commun. Apr. 8(1), 3003 (2024). https:\/\/doi.org\/10.1038\/s41467-024-47273-w","journal-title":"Nat. Commun. Apr"},{"issue":"6","key":"1103_CR28","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1002\/ctm2.947","volume":"12","author":"X Qian","year":"2022","unstructured":"X. Qian, H.Y. Zhang, Q.L. Li et al., Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer. Clin. Translational Med. Jun. 12(6), e947 (2022). https:\/\/doi.org\/10.1002\/ctm2.947","journal-title":"Clin. Translational Med. Jun"},{"issue":"10","key":"1103_CR29","first-page":"3171","volume":"10","author":"WQ Zhang","year":"2018","unstructured":"W.Q. Zhang, S.K. Zhao, J.W. Luo et al., Alterations of fecal bacterial communities in patients with lung cancer. Am. J. Translational Res. 10(10), 3171\u20133185 (2018)","journal-title":"Am. J. Translational Res."},{"issue":"4","key":"1103_CR30","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1080\/19490976.2020.1737487","volume":"3","author":"Y Zheng","year":"2020","unstructured":"Y. Zheng, Z. Fang, Y. Xue et al., Specific gut Microbiome signature predicts the early-stage lung cancer. Gut Microbes Jul. 3(4), 1030\u20131042 (2020). https:\/\/doi.org\/10.1080\/19490976.2020.1737487","journal-title":"Gut Microbes Jul"},{"key":"1103_CR31","doi-asserted-by":"publisher","unstructured":"H. Zhuang, L. Cheng, Y. Wang et al., Dysbiosis of the gut Microbiome in lung cancer. Frontiers in cellular and infection microbiology. 9:112 (2019). https:\/\/doi.org\/10.3389\/fcimb.2019.00112","DOI":"10.3389\/fcimb.2019.00112"},{"key":"1103_CR32","doi-asserted-by":"publisher","unstructured":"Y. Guo, W. Yuan, N. Lyu et al., Association studies on gut and lung microbiomes in patients with lung adenocarcinoma. Microorganisms Feb. 21(3) (2023). https:\/\/doi.org\/10.3390\/microorganisms11030546","DOI":"10.3390\/microorganisms11030546"},{"issue":"8","key":"1103_CR33","doi-asserted-by":"publisher","first-page":"e23318","DOI":"10.1002\/jcla.23318","volume":"34","author":"Q Gui","year":"2020","unstructured":"Q. Gui, H. Li, A. Wang et al., The association between gut butyrate-producing bacteria and non-small-cell lung cancer. J. Clin. Lab. Anal. Aug. 34(8), e23318 (2020). https:\/\/doi.org\/10.1002\/jcla.23318","journal-title":"J. Clin. Lab. Anal. Aug"},{"key":"1103_CR34","doi-asserted-by":"publisher","first-page":"5035371","DOI":"10.1155\/2017\/5035371","volume":"2017","author":"R Bingula","year":"2017","unstructured":"R. Bingula, M. Filaire, N. Radosevic-Robin et al., Desired turbulence? Gut-Lung axis, immunity, and lung cancer. J. Oncol. 2017, 5035371 (2017). https:\/\/doi.org\/10.1155\/2017\/5035371","journal-title":"J. Oncol."},{"key":"1103_CR35","doi-asserted-by":"publisher","unstructured":"L.B. Bindels, A.M. Neyrinck, A. Loumaye et al., Increased gut permeability in cancer cachexia: mechanisms and clinical relevance. Oncotarget. 9(26):18224\u201318238. (Apr 6. 2018). https:\/\/doi.org\/10.18632\/oncotarget.24804","DOI":"10.18632\/oncotarget.24804"},{"issue":"1","key":"1103_CR36","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1038\/s41467-023-38058-8","volume":"9","author":"B Seelbinder","year":"2023","unstructured":"B. Seelbinder, Z. Lohinai, R. Vazquez-Uribe et al., Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions. Nat. Commun. May. 9(1), 2673 (2023). https:\/\/doi.org\/10.1038\/s41467-023-38058-8","journal-title":"Nat. Commun. May"},{"issue":"2","key":"1103_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.trecan.2019.12.007","volume":"6","author":"AG Ram\u00edrez-Labrada","year":"2020","unstructured":"A.G. Ram\u00edrez-Labrada, D. Isla, A. Artal et al., The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy. Trends Cancer Feb. 6(2), 86\u201397 (2020). https:\/\/doi.org\/10.1016\/j.trecan.2019.12.007","journal-title":"Trends Cancer Feb"},{"key":"1103_CR38","doi-asserted-by":"publisher","unstructured":"E.S. Charlson, K. Bittinger, A.R. Haas et al., Topographical continuity of bacterial populations in the healthy human respiratory tract. American journal of respiratory and critical care medicine. 184(8):957\u2009\u2013\u200963 (Oct 15. 2011). https:\/\/doi.org\/10.1164\/rccm.201104-0655OC","DOI":"10.1164\/rccm.201104-0655OC"},{"issue":"2","key":"1103_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/mi.2016.108","volume":"10","author":"GB Huffnagle","year":"2017","unstructured":"G.B. Huffnagle, R.P. Dickson, N.W. Lukacs, The respiratory tract Microbiome and lung inflammation: a two-way street. Mucosal Immunol. Mar. 10(2), 299\u2013306 (2017). https:\/\/doi.org\/10.1038\/mi.2016.108","journal-title":"Mucosal Immunol. Mar."},{"key":"1103_CR40","doi-asserted-by":"publisher","unstructured":"C.M. Bassis, J.R. Erb-Downward, R.P. Dickson et al., Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. mBio. Mar 3 2015;6(2):e00037. https:\/\/doi.org\/10.1128\/mBio.00037-15","DOI":"10.1128\/mBio.00037-15"},{"issue":"3","key":"1103_CR41","doi-asserted-by":"publisher","first-page":"e0031423","DOI":"10.1128\/spectrum.00314-23","volume":"15","author":"Y Sun","year":"2023","unstructured":"Y. Sun, Y. Liu, J. Li et al., Characterization of lung and oral microbiomes in lung cancer patients using culturomics and 16S rRNA gene sequencing. Microbiol. Spectr. Jun. 15(3), e0031423 (2023). https:\/\/doi.org\/10.1128\/spectrum.00314-23","journal-title":"Microbiol. Spectr. Jun"},{"issue":"10","key":"1103_CR42","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1164\/rccm.201210-1913OC","volume":"15","author":"A Morris","year":"2013","unstructured":"A. Morris, J.M. Beck, P.D. Schloss et al., Comparison of the respiratory Microbiome in healthy nonsmokers and smokers. American journal of respiratory and critical care medicine. May. 15(10), 1067\u20131075 (2013). https:\/\/doi.org\/10.1164\/rccm.201210-1913OC","journal-title":"May"},{"key":"1103_CR43","doi-asserted-by":"publisher","first-page":"16031","DOI":"10.1038\/nmicrobiol.2016.31","volume":"4","author":"LN Segal","year":"2016","unstructured":"L.N. Segal, J.C. Clemente, J.C. Tsay et al., Enrichment of the lung Microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. Apr. 4, 1:16031 (2016). https:\/\/doi.org\/10.1038\/nmicrobiol.2016.31","journal-title":"Nat. Microbiol. Apr"},{"issue":"6","key":"1103_CR44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1513\/AnnalsATS.201501-029OC","volume":"12","author":"RP Dickson","year":"2015","unstructured":"R.P. Dickson, J.R. Erb-Downward, C.M. Freeman et al., Spatial variation in the healthy human lung Microbiome and the adapted Island model of lung biogeography. Annals Am. Thorac. Soc. Jun. 12(6), 821\u2013830 (2015). https:\/\/doi.org\/10.1513\/AnnalsATS.201501-029OC","journal-title":"Annals Am. Thorac. Soc. Jun"},{"key":"1103_CR45","doi-asserted-by":"publisher","unstructured":"S. Bello, J.J. Vengoechea, M. Ponce-Alonso et al., Core microbiota in central lung cancer with Streptococcal enrichment as a possible diagnostic marker. Archivos de bronconeumologia. (Jun 30 2020). https:\/\/doi.org\/10.1016\/j.arbres.2020.05.034","DOI":"10.1016\/j.arbres.2020.05.034"},{"key":"1103_CR46","doi-asserted-by":"publisher","unstructured":"A. Venkataraman, C.M. Bassis, J.M. Beck et al., Application of a neutral community model to assess structuring of the human lung Microbiome. mBio Jan. 20(1) (2015). https:\/\/doi.org\/10.1128\/mBio.02284-14","DOI":"10.1128\/mBio.02284-14"},{"issue":"5","key":"1103_CR47","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/ismej.2014.250","volume":"9","author":"JC Stearns","year":"2015","unstructured":"J.C. Stearns, C.J. Davidson, S. McKeon et al., Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J. May. 9(5), 1246\u20131259 (2015). https:\/\/doi.org\/10.1038\/ismej.2014.250","journal-title":"ISME J. May"},{"issue":"5","key":"1103_CR48","doi-asserted-by":"publisher","first-page":"e10598","DOI":"10.1371\/journal.pone.0010598","volume":"17","author":"DN Frank","year":"2010","unstructured":"D.N. Frank, L.M. Feazel, M.T. Bessesen, C.S. Price, E.N. Janoff, N.R. Pace, The human nasal microbiota and Staphylococcus aureus carriage. PloS One May. 17(5), e10598 (2010). https:\/\/doi.org\/10.1371\/journal.pone.0010598","journal-title":"PloS One May"},{"issue":"3","key":"1103_CR49","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/s2213-2600(14)70028-1","volume":"2","author":"RP Dickson","year":"2014","unstructured":"R.P. Dickson, J.R. Erb-Downward, G.B. Huffnagle, Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Respiratory Med. Mar. 2(3), 238\u2013246 (2014). https:\/\/doi.org\/10.1016\/s2213-2600(14)70028-1","journal-title":"Lancet Respiratory Med. Mar."},{"issue":"14","key":"1103_CR50","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00018-020-03452-8","volume":"77","author":"M Sommariva","year":"2020","unstructured":"M. Sommariva, Le V. Noci, F. Bianchi et al., The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell. Mol. Life Sci. : CMLS Jul. 77(14), 2739\u20132749 (2020). https:\/\/doi.org\/10.1007\/s00018-020-03452-8","journal-title":"Cell. Mol. Life Sci. : CMLS Jul"},{"key":"1103_CR51","doi-asserted-by":"publisher","unstructured":"T. Goto, Airway microbiota as a modulator of lung cancer. Int. J. Mol. Sci. Apr. 26(9) (2020). https:\/\/doi.org\/10.3390\/ijms21093044","DOI":"10.3390\/ijms21093044"},{"key":"1103_CR52","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3389\/fonc.2020.01584","volume":"10","author":"M Zhuo","year":"2020","unstructured":"M. Zhuo, T. An, C. Zhang, Z. Wang, Characterization of microbiota in cancerous lung and the contralateral Non-Cancerous lung within lung cancer patients. Front. Oncol. 10, 1584 (2020). https:\/\/doi.org\/10.3389\/fonc.2020.01584","journal-title":"Front. Oncol."},{"issue":"3","key":"1103_CR53","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1080\/21655979.2022.2045843","volume":"13","author":"W Zeng","year":"2022","unstructured":"W. Zeng, C. Zhao, M. Yu et al., Alterations of lung microbiota in patients with non-small cell lung cancer. Bioengineered Mar. 13(3), 6665\u20136677 (2022). https:\/\/doi.org\/10.1080\/21655979.2022.2045843","journal-title":"Bioengineered Mar."},{"key":"1103_CR54","doi-asserted-by":"publisher","unstructured":"H.D. 3 Hosgood rd, A.R. Sapkota, N. Rothman et al., The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ. Mol. Mutagen. Oct. 55(8), 643\u2013651 (2014). https:\/\/doi.org\/10.1002\/em.21878","DOI":"10.1002\/em.21878"},{"key":"1103_CR55","doi-asserted-by":"publisher","unstructured":"E. Baranova, V. Druzhinin, L. Matskova et al., Sputum Microbiome composition in patients with squamous cell lung carcinoma. Life (Basel, Switzerland). Sep. 1(9) (2022). https:\/\/doi.org\/10.3390\/life12091365","DOI":"10.3390\/life12091365"},{"issue":"2","key":"1103_CR56","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1097\/js9.0000000000002152","volume":"1","author":"Q Ma","year":"2025","unstructured":"Q. Ma, C.X. Huang, J.W. He et al., Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study. Int. J. Surg. (London England) Feb. 1(2), 2055\u20132071 (2025). https:\/\/doi.org\/10.1097\/js9.0000000000002152","journal-title":"Int. J. Surg. (London England) Feb"},{"issue":"11","key":"1103_CR57","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/jnci\/djac149","volume":"14","author":"E Vogtmann","year":"2022","unstructured":"E. Vogtmann, X. Hua, G. Yu et al., The oral Microbiome and lung cancer risk: an analysis of 3 prospective cohort studies. J. Natl. Cancer Inst. Nov. 14(11), 1501\u20131510 (2022). https:\/\/doi.org\/10.1093\/jnci\/djac149","journal-title":"J. Natl. Cancer Inst. Nov"},{"key":"1103_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"S.H. Lee, J.Y. Sung, D. Yong et al., Characterization of Microbiome in Bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung cancer (Amsterdam, Netherlands). Dec. 102, 89\u201395 (2016). https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.016","journal-title":"Dec"},{"issue":"9","key":"1103_CR59","first-page":"2047","volume":"9","author":"D Huang","year":"2019","unstructured":"D. Huang, X. Su, M. Yuan et al., The characterization of lung Microbiome in lung cancer patients with different clinicopathology. Am. J. Cancer Res. 9(9), 2047\u20132063 (2019)","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"1103_CR60","doi-asserted-by":"publisher","first-page":"12838","DOI":"10.1038\/s41598-019-49195-w","volume":"6","author":"S Gomes","year":"2019","unstructured":"S. Gomes, B. Cavadas, J.C. Ferreira et al., Profiling of lung microbiota discloses differences in adenocarcinoma and squamous cell carcinoma. Sci. Rep. Sep. 6(1), 12838 (2019). https:\/\/doi.org\/10.1038\/s41598-019-49195-w","journal-title":"Sci. Rep. Sep."},{"issue":"3","key":"1103_CR61","doi-asserted-by":"publisher","first-page":"693","DOI":"10.21037\/tlcr-19-590","volume":"9","author":"C Cheng","year":"2020","unstructured":"C. Cheng, Z. Wang, J. Wang et al., Characterization of the lung Microbiome and exploration of potential bacterial biomarkers for lung cancer. Translational Lung Cancer Res. Jun. 9(3), 693\u2013704 (2020). https:\/\/doi.org\/10.21037\/tlcr-19-590","journal-title":"Translational Lung Cancer Res. Jun"},{"issue":"5","key":"1103_CR62","doi-asserted-by":"publisher","first-page":"e0177062","DOI":"10.1371\/journal.pone.0177062","volume":"12","author":"SJS Cameron","year":"2017","unstructured":"S.J.S. Cameron, K.E. Lewis, S.A. Huws et al., A pilot study using metagenomic sequencing of the sputum Microbiome suggests potential bacterial biomarkers for lung cancer. PloS One. 12(5), e0177062 (2017). https:\/\/doi.org\/10.1371\/journal.pone.0177062","journal-title":"PloS One"},{"issue":"1","key":"1103_CR63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1183\/09031936.00062212","volume":"42","author":"S Laroumagne","year":"2013","unstructured":"S. Laroumagne, B. Lepage, C. Hermant et al., Bronchial colonisation in patients with lung cancer: a prospective study. Eur. Respiratory J. Jul. 42(1), 220\u2013229 (2013). https:\/\/doi.org\/10.1183\/09031936.00062212","journal-title":"Eur. Respiratory J. Jul"},{"key":"1103_CR64","doi-asserted-by":"publisher","unstructured":"Q. Yuan, X. Wang, Z. Li, W. Guo, H. Cheng, Q. Cao, A preliminary study on microbiota characteristics of Bronchoalveolar lavage fluid in patients with pulmonary nodules based on metagenomic Next-Generation sequencing. Biomedicines Feb. 20(2) (2023). https:\/\/doi.org\/10.3390\/biomedicines11020631","DOI":"10.3390\/biomedicines11020631"},{"issue":"1","key":"1103_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13059-016-1021-1","volume":"28","author":"G Yu","year":"2016","unstructured":"G. Yu, M.H. Gail, D. Consonni et al., Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biology Jul. 28(1), 163 (2016). https:\/\/doi.org\/10.1186\/s13059-016-1021-1","journal-title":"Genome Biology Jul"},{"key":"1103_CR66","doi-asserted-by":"publisher","unstructured":"A. Fu, B. Yao, T. Dong et al., Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. Apr 14. 2022;185(8):1356\u20131372.e26. https:\/\/doi.org\/10.1016\/j.cell.2022.02.027","DOI":"10.1016\/j.cell.2022.02.027"},{"issue":"1","key":"1103_CR67","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"MC Dieu-Nosjean","year":"2016","unstructured":"M.C. Dieu-Nosjean, N.A. Giraldo, H. Kaplon, C. Germain, W.H. Fridman, C. Saut\u00e8s-Fridman, Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunological Reviews May. 271(1), 260\u2013275 (2016). https:\/\/doi.org\/10.1111\/imr.12405","journal-title":"Immunological Reviews May"},{"key":"1103_CR68","doi-asserted-by":"publisher","unstructured":"A. Wong-Rolle, Q. Dong, Y. Zhu et al., Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature. J. Immunotherapy Cancer Jul. 10(7) (2022). https:\/\/doi.org\/10.1136\/jitc-2022-004698","DOI":"10.1136\/jitc-2022-004698"},{"issue":"4","key":"1103_CR69","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.31098","volume":"15","author":"HX Liu","year":"2018","unstructured":"H.X. Liu, L.L. Tao, J. Zhang et al., Difference of lower airway Microbiome in bilateral protected specimen brush between lung cancer patients with unilateral Lobar masses and control subjects. Int. J. Cancer Feb. 15(4), 769\u2013778 (2018). https:\/\/doi.org\/10.1002\/ijc.31098","journal-title":"Int. J. Cancer Feb"},{"issue":"11","key":"1103_CR70","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.21037\/tlcr-23-357","volume":"30","author":"P Liang","year":"2023","unstructured":"P. Liang, H. Deng, Y. Zhao et al., Microbiota modulate lung squamous cell carcinoma lymph node metastasis through microbiota-geneset correlation network. Translational Lung Cancer Res. Nov. 30(11), 2245\u20132259 (2023). https:\/\/doi.org\/10.21037\/tlcr-23-357","journal-title":"Translational Lung Cancer Res. Nov"},{"issue":"6","key":"1103_CR71","doi-asserted-by":"publisher","first-page":"101050","DOI":"10.1016\/j.tranon.2021.101050","volume":"14","author":"Y Ma","year":"2021","unstructured":"Y. Ma, M. Qiu, S. Wang, S. Meng, F. Yang, G. Jiang, Distinct tumor bacterial Microbiome in lung adenocarcinomas manifested as radiological subsolid nodules. Translational Oncol. Jun. 14(6), 101050 (2021). https:\/\/doi.org\/10.1016\/j.tranon.2021.101050","journal-title":"Translational Oncol. Jun"},{"key":"1103_CR72","doi-asserted-by":"publisher","first-page":"847182","DOI":"10.3389\/fonc.2023.847182","volume":"13","author":"X Zheng","year":"2023","unstructured":"X. Zheng, X. Lu, Y. Hu, Distinct respiratory microbiota associates with lung cancer clinicopathological characteristics. Front. Oncol. 13, 847182 (2023). https:\/\/doi.org\/10.3389\/fonc.2023.847182","journal-title":"Front. Oncol."},{"issue":"Pt 3","key":"1103_CR73","doi-asserted-by":"publisher","first-page":"141542","DOI":"10.1016\/j.ijbiomac.2025.141542","volume":"306","author":"U Sagheer","year":"2025","unstructured":"U. Sagheer, J. Shu, H. Yu et al., Protein glycopatterns for natural regulation of microbiota in lung adenocarcinoma. Int. J. Biol. Macromol. May. 306(Pt 3), 141542 (2025). https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.141542","journal-title":"Int. J. Biol. Macromol. May"},{"issue":"7Supplement","key":"1103_CR74","doi-asserted-by":"publisher","first-page":"5909","DOI":"10.1158\/1538-7445.AM","volume":"83","author":"J McElderry","year":"2023","unstructured":"J. McElderry, T. Zhang, J. Shi, M.T. Landi, Abstract 5909: characterization of the lung cancer Microbiome using whole genome sequencing. Cancer Res. 83(7Supplement), 5909\u20135909 (2023). https:\/\/doi.org\/10.1158\/1538-7445.AM. 2023-5909%J Cancer Research","journal-title":"Cancer Res."},{"key":"1103_CR75","doi-asserted-by":"publisher","unstructured":"V. Ankudavicius, D. Nikitina, R. Lukosevicius et al., Detailed characterization of the lung-Gut Microbiome axis reveals the link between PD-L1 and the Microbiome in Non-Small-Cell lung cancer patients. Int. J. Mol. Sci. Feb. 15(4) (2024). https:\/\/doi.org\/10.3390\/ijms25042323","DOI":"10.3390\/ijms25042323"},{"key":"1103_CR76","doi-asserted-by":"publisher","first-page":"1589843","DOI":"10.3389\/fimmu.2025.1589843","volume":"16","author":"J Cheng","year":"2025","unstructured":"J. Cheng, H. Wang, Lung Microbiome alterations correlate with immune imbalance in non-small cell lung cancer. Front. Immunol. 16, 1589843 (2025). https:\/\/doi.org\/10.3389\/fimmu.2025.1589843","journal-title":"Front. Immunol."},{"issue":"7Supplement","key":"1103_CR77","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1158\/1538-7445.AM","volume":"83","author":"EM Riquelme","year":"2023","unstructured":"E.M. Riquelme, I. Valdes, C. Aravena et al., Abstract 651: revealing the role of lung cancer microbiota in the tumor progression. Cancer Res. 83(7Supplement), 651\u2013651 (2023). https:\/\/doi.org\/10.1158\/1538-7445.AM. 2023-651%J Cancer Research","journal-title":"Cancer Res."},{"key":"1103_CR78","doi-asserted-by":"publisher","first-page":"1397989","DOI":"10.3389\/fcimb.2024.1397989","volume":"14","author":"K Yang","year":"2024","unstructured":"K. Yang, S. Wang, Z. Ding et al., Unveiling microbial dynamics in lung adenocarcinoma and adjacent nontumor tissues: insights from nicotine exposure and diverse clinical stages via nanopore sequencing technology. Front. Cell. Infect. Microbiol. 14, 1397989 (2024). https:\/\/doi.org\/10.3389\/fcimb.2024.1397989","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1103_CR79","doi-asserted-by":"publisher","first-page":"946995","DOI":"10.3389\/fmicb.2022.946995","volume":"13","author":"L Zhang","year":"2022","unstructured":"L. Zhang, D. Chai, C. Chen et al., Mycobiota and C-Type lectin receptors in cancers: know Thy neighbors. Front. Microbiol. 13, 946995 (2022). https:\/\/doi.org\/10.3389\/fmicb.2022.946995","journal-title":"Front. Microbiol."},{"issue":"3","key":"1103_CR80","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4143\/crt.2019.606","volume":"52","author":"L Pan","year":"2020","unstructured":"L. Pan, Y. Tan, B. Wang et al., Caspase recruitment domain containing protein 9 suppresses Non-Small cell lung cancer proliferation and invasion via inhibiting MAPK\/p38 pathway. Cancer Res. Treat. Jul. 52(3), 867\u2013885 (2020). https:\/\/doi.org\/10.4143\/crt.2019.606","journal-title":"Cancer Res. Treat. Jul"},{"issue":"1","key":"1103_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12866-023-02790-4","volume":"25","author":"Y Zhao","year":"2023","unstructured":"Y. Zhao, J. Yi, J. Xiang et al., Exploration of lung mycobiome in the patients with non-small-cell lung cancer. BMC Microbiol. Mar. 25(1), 81 (2023). https:\/\/doi.org\/10.1186\/s12866-023-02790-4","journal-title":"BMC Microbiol. Mar."},{"issue":"20","key":"1103_CR82","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"29","author":"L Narunsky-Haziza","year":"2022","unstructured":"L. Narunsky-Haziza, G.D. Sepich-Poore, I. Livyatan et al., Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. Sep. 29(20), 3789\u20133806e17 (2022). https:\/\/doi.org\/10.1016\/j.cell.2022.09.005","journal-title":"Cell. Sep."},{"issue":"11","key":"1103_CR83","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.ccell.2023.08.012","volume":"13","author":"NN Liu","year":"2023","unstructured":"N.N. Liu, C.X. Yi, L.Q. Wei et al., The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells. Cancer Cell. Nov. 13(11), 1927\u20131944e9 (2023). https:\/\/doi.org\/10.1016\/j.ccell.2023.08.012","journal-title":"Cancer Cell. Nov"},{"issue":"20","key":"1103_CR84","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"29","author":"AB Dohlman","year":"2022","unstructured":"A.B. Dohlman, J. Klug, M. Mesko et al., A pan-cancer mycobiome analysis reveals fungal involvement in Gastrointestinal and lung tumors. Cell. Sep. 29(20), 3807\u20133822e12 (2022). https:\/\/doi.org\/10.1016\/j.cell.2022.09.015","journal-title":"Cell. Sep."},{"key":"1103_CR85","doi-asserted-by":"publisher","unstructured":"Y.-J. Ma, Y.-C. Sun, L. Wang et al., Dissection of intratumor microbiome\u2013host interactions at single-cell level in lung cancer. hLife 2024\/09\/13\/ (2024). https:\/\/doi.org\/10.1016\/j.hlife.2024.09.001","DOI":"10.1016\/j.hlife.2024.09.001"},{"issue":"7","key":"1103_CR86","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1093\/nar\/gkad199","volume":"24","author":"L Py\u00f6ri\u00e4","year":"2023","unstructured":"L. Py\u00f6ri\u00e4, D. Pratas, M. Toppinen, K. Hedman, A. Sajantila, M.F. Perdomo, Unmasking the tissue-resident eukaryotic DNA Virome in humans. Nucleic Acids Res. Apr. 24(7), 3223\u20133239 (2023). https:\/\/doi.org\/10.1093\/nar\/gkad199","journal-title":"Nucleic Acids Res. Apr"},{"issue":"3","key":"1103_CR87","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/path.2188","volume":"212","author":"H Zheng","year":"2007","unstructured":"H. Zheng, H.O. Abdel Aziz, Y. Nakanishi et al., Oncogenic role of JC virus in lung cancer. J. Pathol. Jul. 212(3), 306\u2013315 (2007). https:\/\/doi.org\/10.1002\/path.2188","journal-title":"J. Pathol. Jul"},{"issue":"56","key":"1103_CR88","doi-asserted-by":"publisher","first-page":"96419","DOI":"10.18632\/oncotarget.21682","volume":"10","author":"WM Xiong","year":"2017","unstructured":"W.M. Xiong, Q.P. Xu, X. Li, R.D. Xiao, L. Cai, F. He, The association between human papillomavirus infection and lung cancer: a system review and meta-analysis. Oncotarget Nov. 10(56), 96419\u201396432 (2017). https:\/\/doi.org\/10.18632\/oncotarget.21682","journal-title":"Oncotarget Nov"},{"key":"1103_CR89","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.micpath.2020.104692","volume":"150","author":"BM Hussen","year":"2021","unstructured":"B.M. Hussen, G. Ahmadi, H. Marzban et al., The role of HPV gene expression and selected cellular MiRNAs in lung cancer development. Microb. Pathogenesis Jan. 150, 104692 (2021). https:\/\/doi.org\/10.1016\/j.micpath.2020.104692","journal-title":"Microb. Pathogenesis Jan"},{"issue":"1","key":"1103_CR90","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/cco.0000000000000703","volume":"33","author":"F Wu","year":"2021","unstructured":"F. Wu, L. Wang, C. Zhou, Lung cancer in china: current and prospect. Curr. Opin. Oncol. Jan. 33(1), 40\u201346 (2021). https:\/\/doi.org\/10.1097\/cco.0000000000000703","journal-title":"Curr. Opin. Oncol. Jan"},{"key":"1103_CR91","doi-asserted-by":"publisher","unstructured":"J.C. Osorio, A. Armijo, F.J. Carvajal et al., Epstein-Barr virus BARF1 is expressed in lung cancer and is associated with cancer progression. Cells Sep. 19(18) (2024). https:\/\/doi.org\/10.3390\/cells13181578","DOI":"10.3390\/cells13181578"},{"issue":"4","key":"1103_CR92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/bjc.2016.213","volume":"115","author":"LA Robinson","year":"2016","unstructured":"L.A. Robinson, C.J. Jaing, C. Pierce Campbell et al., Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung. Br. J. Cancer Aug 9. 115(4), 497\u2013504 (2016). https:\/\/doi.org\/10.1038\/bjc.2016.213","journal-title":"Br. J. Cancer Aug 9"},{"key":"1103_CR93","doi-asserted-by":"publisher","unstructured":"F. Kheir, M. Zhao, M.J. Strong et al., Detection of Epstein-Barr virus infection in Non-Small cell lung cancer. Cancers May. 31(6) (2019). https:\/\/doi.org\/10.3390\/cancers11060759","DOI":"10.3390\/cancers11060759"},{"key":"1103_CR94","doi-asserted-by":"publisher","unstructured":"D. Becnel, R. Abdelghani, A. Nanbo et al., Pathogenic role of Epstein-Barr virus in lung cancers. Viruses May. 11(5) (2021). https:\/\/doi.org\/10.3390\/v13050877","DOI":"10.3390\/v13050877"},{"issue":"2","key":"1103_CR95","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jtho.2021.11.001","volume":"17","author":"C Rolfo","year":"2022","unstructured":"C. Rolfo, N. Meshulami, A. Russo et al., Lung cancer and severe acute respiratory syndrome coronavirus 2 infection: identifying important knowledge gaps for investigation. Journal of thoracic oncology : official publication of the international association for the study of lung cancer. Feb. 17(2), 214\u2013227 (2022). https:\/\/doi.org\/10.1016\/j.jtho.2021.11.001","journal-title":"Feb"},{"issue":"2","key":"1103_CR96","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/jcb.21647","volume":"15","author":"S Jiang","year":"2008","unstructured":"S. Jiang, S. Zhang, J. Langenfeld, S.C. Lo, M.B. Rogers, Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by post-transcriptional mechanisms. J. Cell. Biochem. May. 15(2), 580\u2013594 (2008). https:\/\/doi.org\/10.1002\/jcb.21647","journal-title":"J. Cell. Biochem. May"},{"issue":"36","key":"1103_CR97","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.1073\/pnas.1707009114","volume":"5","author":"M Kowarsky","year":"2017","unstructured":"M. Kowarsky, J. Camunas-Soler, M. Kertesz et al., Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by Circulating cell-free DNA. Proc. Natl. Acad. Sci. United States Am. Sep. 5(36), 9623\u20139628 (2017). https:\/\/doi.org\/10.1073\/pnas.1707009114","journal-title":"Proc. Natl. Acad. Sci. United States Am. Sep."},{"issue":"1","key":"1103_CR98","doi-asserted-by":"publisher","first-page":"pbac005","DOI":"10.1093\/pcmedi\/pbac005","volume":"5","author":"L You","year":"2022","unstructured":"L. You, J. Zhou, Z. Xin et al., Novel directions of precision oncology: Circulating microbial DNA emerging in cancer-microbiome areas. Precision Clin. Med. Mar. 5(1), pbac005 (2022). https:\/\/doi.org\/10.1093\/pcmedi\/pbac005","journal-title":"Precision Clin. Med. Mar."},{"key":"1103_CR99","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.canlet.2020.11.030","volume":"499","author":"Q Xiao","year":"2021","unstructured":"Q. Xiao, W. Lu, X. Kong et al., Alterations of Circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study. Cancer Lett. Feb 28. 499, 201\u2013208 (2021). https:\/\/doi.org\/10.1016\/j.canlet.2020.11.030","journal-title":"Cancer Lett. Feb 28"},{"issue":"4","key":"1103_CR100","doi-asserted-by":"publisher","first-page":"101499","DOI":"10.1016\/j.xcrm.2024.101499","volume":"16","author":"H Chen","year":"2024","unstructured":"H. Chen, Y. Ma, J. Xu et al., Circulating Microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer. Cell. Rep. Med. Apr. 16(4), 101499 (2024). https:\/\/doi.org\/10.1016\/j.xcrm.2024.101499","journal-title":"Cell. Rep. Med. Apr"},{"issue":"4","key":"1103_CR101","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.1016\/j.xcrm.2024.101488","volume":"16","author":"Y Ma","year":"2024","unstructured":"Y. Ma, H. Chen, H. Li et al., Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell. Rep. Med. Apr. 16(4), 101488 (2024). https:\/\/doi.org\/10.1016\/j.xcrm.2024.101488","journal-title":"Cell. Rep. Med. Apr"},{"key":"1103_CR102","unstructured":"M. Muraca, L. Putignani, A. Fierabracci, A. Teti, G. Perilongo, May. Gut microbiota-derived outer membrane vesicles: under-recognized major players in health and disease? Discovery medicine. 19(106):343\u2013348 (2015)."},{"issue":"6","key":"1103_CR103","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","volume":"71","author":"J Mouries","year":"2019","unstructured":"J. Mouries, P. Brescia, A. Silvestri et al., Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. J. Hepatol. Dec. 71(6), 1216\u20131228 (2019). https:\/\/doi.org\/10.1016\/j.jhep.2019.08.005","journal-title":"J. Hepatol. Dec."},{"key":"1103_CR104","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2019.00502","volume":"10","author":"B Duvvuri","year":"2019","unstructured":"B. Duvvuri, C. Lood, Cell-Free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol. 10, 502 (2019). https:\/\/doi.org\/10.3389\/fimmu.2019.00502","journal-title":"Front. Immunol."},{"issue":"1","key":"1103_CR105","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s13287-020-01887-1","volume":"27","author":"A Accarie","year":"2020","unstructured":"A. Accarie, B. l\u2019Homme, M.A. Benadjaoud et al., Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome. Stem Cell. Res. Therapy Aug. 27(1), 371 (2020). https:\/\/doi.org\/10.1186\/s13287-020-01887-1","journal-title":"Stem Cell. Res. Therapy Aug"},{"issue":"1","key":"1103_CR106","doi-asserted-by":"publisher","first-page":"7536","DOI":"10.1038\/s41598-019-44012-w","volume":"17","author":"EJ Cho","year":"2019","unstructured":"E.J. Cho, S. Leem, S.A. Kim et al., Circulating Microbiota-Based metagenomic signature for detection of hepatocellular carcinoma. Sci. Rep. May. 17(1), 7536 (2019). https:\/\/doi.org\/10.1038\/s41598-019-44012-w","journal-title":"Sci. Rep. May"},{"issue":"1","key":"1103_CR107","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12967-023-04582-w","volume":"10","author":"X Zhou","year":"2023","unstructured":"X. Zhou, L. You, Z. Xin, H. Su, J. Zhou, Y. Ma, Leveraging Circulating Microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer. J. Translational Med. Nov. 10(1), 800 (2023). https:\/\/doi.org\/10.1186\/s12967-023-04582-w","journal-title":"J. Translational Med. Nov"},{"issue":"3","key":"1103_CR108","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/thoraxjnl-2020-215542","volume":"76","author":"HD Hosgood","year":"2021","unstructured":"H.D. Hosgood, Q. Cai, X. Hua et al., Variation in oral Microbiome is associated with future risk of lung cancer among never-smokers. Thorax Mar. 76(3), 256\u2013263 (2021). https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215542","journal-title":"Thorax Mar."},{"issue":"1","key":"1103_CR109","doi-asserted-by":"publisher","first-page":"100972","DOI":"10.1016\/j.tranon.2020.100972","volume":"14","author":"Y Liu","year":"2021","unstructured":"Y. Liu, X. Yuan, K. Chen et al., Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer. Translational Oncol. Jan. 14(1), 100972 (2021). https:\/\/doi.org\/10.1016\/j.tranon.2020.100972","journal-title":"Translational Oncol. Jan"},{"key":"1103_CR110","doi-asserted-by":"publisher","first-page":"1482084","DOI":"10.3389\/fimmu.2024.1482084","volume":"15","author":"Y Deng","year":"2024","unstructured":"Y. Deng, Z.X. Dong, G.H. Yang et al., Streptococcus intermedius promotes synchronous multiple primary lung cancer progression through apoptosis regulation. Front. Immunol. 15, 1482084 (2024). https:\/\/doi.org\/10.3389\/fimmu.2024.1482084","journal-title":"Front. Immunol."},{"issue":"7","key":"1103_CR111","doi-asserted-by":"publisher","first-page":"e41137","DOI":"10.1371\/journal.pone.0041137","volume":"7","author":"Z Xu","year":"2012","unstructured":"Z. Xu, F. Shen, X. Li et al., Molecular and microscopic analysis of bacteria and viruses in exhaled breath collected using a simple impaction and condensing method. PloS One. 7(7), e41137 (2012). https:\/\/doi.org\/10.1371\/journal.pone.0041137","journal-title":"PloS One"},{"key":"1103_CR112","doi-asserted-by":"publisher","unstructured":"G.E. Carpagnano, M. Malerba, D. Lacedonia et al., May. Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma. Allergy and asthma proceedings. 37(3):41\u2009\u2013\u20096 (2016). https:\/\/doi.org\/10.2500\/aap.2016.37.3943","DOI":"10.2500\/aap.2016.37.3943"},{"issue":"2","key":"1103_CR113","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/jb.173.2.697-703.1991","volume":"173","author":"WG Weisburg","year":"1991","unstructured":"W.G. Weisburg, S.M. Barns, D.A. Pelletier, D.J. Lane, 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. Jan. 173(2), 697\u2013703 (1991). https:\/\/doi.org\/10.1128\/jb.173.2.697-703.1991","journal-title":"J. Bacteriol. Jan"},{"issue":"9","key":"1103_CR114","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1128\/jcm.01228-07","volume":"45","author":"JM Janda","year":"2007","unstructured":"J.M. Janda, S.L. Abbott, 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J. Clin. Microbiol. Sep. 45(9), 2761\u20132764 (2007). https:\/\/doi.org\/10.1128\/jcm.01228-07","journal-title":"J. Clin. Microbiol. Sep."},{"issue":"3","key":"1103_CR115","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1128\/aem.00684-07","volume":"74","author":"Z Yu","year":"2008","unstructured":"Z. Yu, R. Garc\u00eda-Gonz\u00e1lez, F.L. Schanbacher, M. Morrison, Evaluations of different hypervariable regions of archaeal 16S rRNA genes in profiling of methanogens by Archaea-specific PCR and denaturing gradient gel electrophoresis. Appl. Environ. Microbiol. Feb. 74(3), 889\u2013893 (2008). https:\/\/doi.org\/10.1128\/aem.00684-07","journal-title":"Appl. Environ. Microbiol. Feb"},{"issue":"1","key":"1103_CR116","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"6","author":"JS Johnson","year":"2019","unstructured":"J.S. Johnson, D.J. Spakowicz, B.Y. Hong et al., Evaluation of 16S rRNA gene sequencing for species and strain-level Microbiome analysis. Nat. Commun. Nov. 6(1), 5029 (2019). https:\/\/doi.org\/10.1038\/s41467-019-13036-1","journal-title":"Nat. Commun. Nov"},{"issue":"2","key":"1103_CR117","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcf.2017.08.007","volume":"17","author":"SK Lucas","year":"2018","unstructured":"S.K. Lucas, R. Yang, J.M. Dunitz, H.C. Boyer, R.C. Hunter, 16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients. J. Cyst. Fibros. : Official J. Eur. Cyst. Fibros. Soc. Mar. 17(2), 204\u2013212 (2018). https:\/\/doi.org\/10.1016\/j.jcf.2017.08.007","journal-title":"J. Cyst. Fibros. : Official J. Eur. Cyst. Fibros. Soc. Mar."},{"key":"1103_CR118","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fgene.2015.00348","volume":"6","author":"A Escobar-Zepeda","year":"2015","unstructured":"A. Escobar-Zepeda, A. Vera-Ponce de Le\u00f3n, A. Sanchez-Flores, The road to metagenomics: from microbiology to DNA sequencing technologies and bioinformatics. Front. Genet. 6, 348 (2015). https:\/\/doi.org\/10.3389\/fgene.2015.00348","journal-title":"Front. Genet."},{"key":"1103_CR119","doi-asserted-by":"publisher","unstructured":"S. Singh, J.G. Natalini, L.N. Segal, May. Lung microbial-host interface through the lens of multi-omics. Mucosal immunology. 15(5):837\u2013845 (2022). https:\/\/doi.org\/10.1038\/s41385-022-00541-8","DOI":"10.1038\/s41385-022-00541-8"},{"issue":"1","key":"1103_CR120","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbz155","volume":"18","author":"R Bharti","year":"2021","unstructured":"R. Bharti, D.G. Grimm, Current challenges and best-practice protocols for Microbiome analysis. Briefings in bioinformatics. Jan. 18(1), 178\u2013193 (2021). https:\/\/doi.org\/10.1093\/bib\/bbz155","journal-title":"Jan"},{"issue":"7945","key":"1103_CR121","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-022-05546-8","volume":"613","author":"KM Kennedy","year":"2023","unstructured":"K.M. Kennedy, de M.C. Goffau, M.E. Perez-Mu\u00f1oz et al., Questioning the fetal Microbiome illustrates pitfalls of low-biomass microbial studies. Nat. Jan. 613(7945), 639\u2013649 (2023). https:\/\/doi.org\/10.1038\/s41586-022-05546-8","journal-title":"Nat. Jan"},{"issue":"2","key":"1103_CR122","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/thoraxjnl-2020-216153","volume":"77","author":"S Pfeiffer","year":"2022","unstructured":"S. Pfeiffer, C. Herzmann, K.I. Gaede, D. Kovacevic, S. Krauss-Etschmann, M. Schloter, Different responses of the oral, nasal and lung microbiomes to cigarette smoke. Thorax Feb. 77(2), 191\u2013195 (2022). https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216153","journal-title":"Thorax Feb"},{"issue":"12","key":"1103_CR123","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1164\/rccm.202001-0197OC","volume":"15","author":"BG Wu","year":"2020","unstructured":"B.G. Wu, B. Kapoor, K.J. Cummings et al., Evidence for Environmental-Human microbiota transfer at a manufacturing facility with novel Work-related respiratory disease. American journal of respiratory and critical care medicine. Dec. 15(12), 1678\u20131688 (2020). https:\/\/doi.org\/10.1164\/rccm.202001-0197OC","journal-title":"Dec"},{"issue":"1","key":"1103_CR124","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaci.2014.06.027","volume":"135","author":"SL Russell","year":"2015","unstructured":"S.L. Russell, M.J. Gold, L.A. Reynolds et al., Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases. J. Allergy Clin. Immunol. Jan. 135(1), 100\u2013109 (2015). https:\/\/doi.org\/10.1016\/j.jaci.2014.06.027","journal-title":"J. Allergy Clin. Immunol. Jan"},{"key":"1103_CR125","doi-asserted-by":"publisher","unstructured":"H.D. 3 Hosgood rd, E.F. Mongodin, Y. Wan et al., The respiratory tract Microbiome and its relationship to lung cancer and environmental exposures found in rural China. Environ. Mol. Mutagen. Aug. 60(7), 617\u2013623 (2019). https:\/\/doi.org\/10.1002\/em.22291","DOI":"10.1002\/em.22291"},{"issue":"13","key":"1103_CR126","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1016\/j.celrep.2018.08.090","volume":"25","author":"V Le Noci","year":"2018","unstructured":"Le V. Noci, S. Guglielmetti, S. Arioli et al., Modulation of pulmonary microbiota by antibiotic or probiotic aerosol therapy: A strategy to promote immunosurveillance against lung metastases. Cell. Rep. Sep. 25(13), 3528\u20133538 (2018). https:\/\/doi.org\/10.1016\/j.celrep.2018.08.090","journal-title":"Cell. Rep. Sep."},{"issue":"1","key":"1103_CR127","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12885-022-09210-2","volume":"24","author":"AF Nyein","year":"2022","unstructured":"A.F. Nyein, S. Bari, S. Hogue et al., Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer. BMC Cancer Jan. 24(1), 101 (2022). https:\/\/doi.org\/10.1186\/s12885-022-09210-2","journal-title":"BMC Cancer Jan"},{"issue":"5","key":"1103_CR128","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"F. Imhann, M.J. Bonder, A. Vich Vila et al., Proton pump inhibitors affect the gut Microbiome. Gut May. 65(5), 740\u2013748 (2016). https:\/\/doi.org\/10.1136\/gutjnl-2015-310376","journal-title":"Gut May"},{"issue":"4","key":"1103_CR129","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cll.2014.08.008","volume":"34","author":"DE Freedberg","year":"2014","unstructured":"D.E. Freedberg, B. Lebwohl, J.A. Abrams, The impact of proton pump inhibitors on the human Gastrointestinal Microbiome. Clin. Lab. Med. Dec. 34(4), 771\u2013785 (2014). https:\/\/doi.org\/10.1016\/j.cll.2014.08.008","journal-title":"Clin. Lab. Med. Dec."},{"issue":"11","key":"1103_CR130","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","volume":"54","author":"RR Kedika","year":"2009","unstructured":"R.R. Kedika, R.F. Souza, S.J. Spechler, Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig. Dis. Sci. Nov. 54(11), 2312\u20132317 (2009). https:\/\/doi.org\/10.1007\/s10620-009-0951-9","journal-title":"Dig. Dis. Sci. Nov"},{"issue":"8","key":"1103_CR131","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ijc.33892","volume":"15","author":"YH Baek","year":"2022","unstructured":"Y.H. Baek, E.J. Kang, S. Hong, S. Park, J.H. Kim, J.Y. Shin, Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors. Int. J. Cancer Apr. 15(8), 1291\u20131300 (2022). https:\/\/doi.org\/10.1002\/ijc.33892","journal-title":"Int. J. Cancer Apr"},{"issue":"7","key":"1103_CR132","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/ni0710-558","volume":"11","author":"N Gill","year":"2010","unstructured":"N. Gill, M. Wlodarska, B.B. Finlay, The future of mucosal immunology: studying an integrated system-wide organ. Nat. Immunol. Jul. 11(7), 558\u2013560 (2010). https:\/\/doi.org\/10.1038\/ni0710-558","journal-title":"Nat. Immunol. Jul"},{"key":"1103_CR133","doi-asserted-by":"publisher","unstructured":"K. Georgiou, B. Marinov, A.A. Farooqi, M. Gazouli, Gut microbiota in lung cancer: where do we stand?? International journal of molecular sciences. Sep. 27(19) (2021). https:\/\/doi.org\/10.3390\/ijms221910429","DOI":"10.3390\/ijms221910429"},{"key":"1103_CR134","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","volume":"38","author":"H Kayama","year":"2020","unstructured":"H. Kayama, R. Okumura, K. Takeda, Interaction between the microbiota, epithelia, and immune cells in the intestine. Annual review of immunology. Apr 26. 38, 23\u201348 (2020). https:\/\/doi.org\/10.1146\/annurev-immunol-070119-115104","journal-title":"Apr 26"},{"issue":"10","key":"1103_CR135","doi-asserted-by":"publisher","first-page":"16113","DOI":"10.1038\/nmicrobiol.2016.113","volume":"18","author":"RP Dickson","year":"2016","unstructured":"R.P. Dickson, B.H. Singer, M.W. Newstead et al., Enrichment of the lung Microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat. Microbiol. Jul. 18(10), 16113 (2016). https:\/\/doi.org\/10.1038\/nmicrobiol.2016.113","journal-title":"Nat. Microbiol. Jul"},{"issue":"6","key":"1103_CR136","doi-asserted-by":"publisher","first-page":"G559","DOI":"10.1152\/ajpgi.00066.2017","volume":"1","author":"JP Karl","year":"2017","unstructured":"J.P. Karl, L.M. Margolis, E.H. Madslien et al., Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress. Am. J. Physiol. Gastrointest. Liver Physiol. Jun. 1(6), G559\u2013g571 (2017). https:\/\/doi.org\/10.1152\/ajpgi.00066.2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol. Jun"},{"issue":"11","key":"1103_CR137","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1164\/rccm.201312-2129PP","volume":"189","author":"KL Whiteson","year":"2014","unstructured":"K.L. Whiteson, B. Bailey, M. Bergkessel et al., The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from Island biogeography. Am. J. Respiratory Crit. Care Med. Jun 1. 189(11), 1309\u20131315 (2014). https:\/\/doi.org\/10.1164\/rccm.201312-2129PP","journal-title":"Am. J. Respiratory Crit. Care Med. Jun 1"},{"issue":"6","key":"1103_CR138","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/mi.2008.61","volume":"1","author":"B Kelsall","year":"2008","unstructured":"B. Kelsall, Recent progress in Understanding the phenotype and function of intestinal dendritic cells and macrophages. Mucosal Immunol. Nov. 1(6), 460\u2013469 (2008). https:\/\/doi.org\/10.1038\/mi.2008.61","journal-title":"Mucosal Immunol. Nov"},{"issue":"6","key":"1103_CR139","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","volume":"21","author":"RJ Hewitt","year":"2021","unstructured":"R.J. Hewitt, C.M. Lloyd, Regulation of immune responses by the airway epithelial cell landscape. Nat. Reviews Immunol. Jun. 21(6), 347\u2013362 (2021). https:\/\/doi.org\/10.1038\/s41577-020-00477-9","journal-title":"Nat. Reviews Immunol. Jun"},{"issue":"2","key":"1103_CR140","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"19","author":"J Schulthess","year":"2019","unstructured":"J. Schulthess, S. Pandey, M. Capitani et al., The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immun. Feb. 19(2), 432\u2013445e7 (2019). https:\/\/doi.org\/10.1016\/j.immuni.2018.12.018","journal-title":"Immun. Feb"},{"issue":"1","key":"1103_CR141","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/SHK.0b013e318259abdb","volume":"38","author":"EE Perrone","year":"2012","unstructured":"E.E. Perrone, E. Jung, E. Breed et al., Mechanisms of methicillin-resistant Staphylococcus aureus pneumonia-induced intestinal epithelial apoptosis. Shock (Augusta, Ga). Jul. 38(1), 68\u201375 (2012). https:\/\/doi.org\/10.1097\/SHK.0b013e318259abdb","journal-title":"Jul"},{"issue":"7195","key":"1103_CR142","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nature07008","volume":"29","author":"SK Mazmanian","year":"2008","unstructured":"S.K. Mazmanian, J.L. Round, D.L. Kasper, A microbial symbiosis factor prevents intestinal inflammatory disease. Nat. May. 29(7195), 620\u2013625 (2008). https:\/\/doi.org\/10.1038\/nature07008","journal-title":"Nat. May"},{"issue":"10","key":"1103_CR143","doi-asserted-by":"publisher","first-page":"e111228","DOI":"10.1371\/journal.pone.0111228","volume":"9","author":"MA Sze","year":"2014","unstructured":"M.A. Sze, M. Tsuruta, S.W. Yang et al., Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PloS One. 9(10), e111228 (2014). https:\/\/doi.org\/10.1371\/journal.pone.0111228","journal-title":"PloS One"},{"key":"1103_CR144","doi-asserted-by":"publisher","unstructured":"S. Yildiz, B. Mazel-Sanchez, M. Kandasamy, B. Manicassamy, M. Schmolke, Influenza A virus infection impacts systemic microbiota dynamics and causes quantitative enteric dysbiosis. Microbiome. 6(1):9 (Jan 10. 2018) https:\/\/doi.org\/10.1186\/s40168-017-0386-z","DOI":"10.1186\/s40168-017-0386-z"},{"issue":"4","key":"1103_CR145","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/gutjnl-2015-309728","volume":"65","author":"TJ Schuijt","year":"2016","unstructured":"T.J. Schuijt, J.M. Lankelma, B.P. Scicluna et al., The gut microbiota plays a protective role in the host defence against Pneumococcal pneumonia. Gut Apr. 65(4), 575\u2013583 (2016). https:\/\/doi.org\/10.1136\/gutjnl-2015-309728","journal-title":"Gut Apr"},{"issue":"4","key":"1103_CR146","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41385-019-0160-6","volume":"12","author":"AT Dang","year":"2019","unstructured":"A.T. Dang, B.J. Marsland, Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. Jul. 12(4), 843\u2013850 (2019). https:\/\/doi.org\/10.1038\/s41385-019-0160-6","journal-title":"Mucosal Immunol. Jul"},{"issue":"10","key":"1103_CR147","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41590-019-0451-9","volume":"20","author":"TP Wypych","year":"2019","unstructured":"T.P. Wypych, L.C. Wickramasinghe, B.J. Marsland, The influence of the Microbiome on respiratory health. Nat. Immunol. Oct. 20(10), 1279\u20131290 (2019). https:\/\/doi.org\/10.1038\/s41590-019-0451-9","journal-title":"Nat. Immunol. Oct."},{"issue":"1","key":"1103_CR148","doi-asserted-by":"publisher","first-page":"2166700","DOI":"10.1080\/19490976.2023.2166700","volume":"15","author":"Z Zhu","year":"2023","unstructured":"Z. Zhu, J. Cai, W. Hou et al., Microbiome and spatially resolved metabolomics analysis reveal the anticancer role of gut Akkermansia muciniphila by crosstalk with intratumoral microbiota and reprogramming tumoral metabolism in mice. Gut Microbes Jan-Dec. 15(1), 2166700 (2023). https:\/\/doi.org\/10.1080\/19490976.2023.2166700","journal-title":"Gut Microbes Jan-Dec"},{"issue":"5","key":"1103_CR149","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.chom.2017.10.007","volume":"22","author":"CP Bradley","year":"2017","unstructured":"C.P. Bradley, F. Teng, K.M. Felix et al., Segmented filamentous bacteria provoke lung autoimmunity by inducing Gut-Lung axis Th17 cells expressing dual tcrs. Cell host & microbe. Nov 8. 22(5), 697\u2013704e4 (2017). https:\/\/doi.org\/10.1016\/j.chom.2017.10.007","journal-title":"Nov 8"},{"key":"1103_CR150","doi-asserted-by":"publisher","unstructured":"M. Murata, Inflammation and cancer. Environmental health and preventive medicine. 23(1):50 (Oct 20. 2018). https:\/\/doi.org\/10.1186\/s12199-018-0740-1","DOI":"10.1186\/s12199-018-0740-1"},{"issue":"3","key":"1103_CR151","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/LBR.0b013e31829ddf01","volume":"20","author":"C Hsu-Kim","year":"2013","unstructured":"C. Hsu-Kim, J.B. Hoag, G.S. Cheng, M.E. Lund, The microbiology of postobstructive pneumonia in lung cancer patients. J. Bronchol. Interventional Pulmonol. Jul. 20(3), 266\u2013270 (2013). https:\/\/doi.org\/10.1097\/LBR.0b013e31829ddf01","journal-title":"J. Bronchol. Interventional Pulmonol. Jul"},{"issue":"4","key":"1103_CR152","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.Epi-04-0599","volume":"14","author":"AJ Littman","year":"2005","unstructured":"A.J. Littman, L.A. Jackson, T.L. Vaughan, Chlamydia pneumoniae and lung cancer: epidemiologic evidence. cancer epidemiology, biomarkers & prevention : a publication of the American association for cancer research. Cosponsored Am. Soc. Prev. Oncol. Apr. 14(4), 773\u2013778 (2005). https:\/\/doi.org\/10.1158\/1055-9965.Epi-04-0599","journal-title":"Cosponsored Am. Soc. Prev. Oncol. Apr"},{"issue":"29","key":"1103_CR153","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1038\/onc.2017.28","volume":"20","author":"C Jungnickel","year":"2017","unstructured":"C. Jungnickel, L.H. Schmidt, L. Bittigkoffer et al., IL-17\u00a0C mediates the recruitment of tumor-associated neutrophils and lung tumor growth. Oncogene Jul. 20(29), 4182\u20134190 (2017). https:\/\/doi.org\/10.1038\/onc.2017.28","journal-title":"Oncogene Jul"},{"issue":"5","key":"1103_CR154","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"21","author":"C Jin","year":"2019","unstructured":"C. Jin, G.K. Lagoudas, C. Zhao et al., Commensal microbiota promote lung cancer development via \u03b3\u03b4 T cells. Cell. Feb. 21(5), 998\u20131013e16 (2019). https:\/\/doi.org\/10.1016\/j.cell.2018.12.040","journal-title":"Cell. Feb"},{"issue":"3","key":"1103_CR155","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ijc.30734","volume":"141","author":"SD Gowing","year":"2017","unstructured":"S.D. Gowing, S.C. Chow, J.J. Cools-Lartigue et al., Gram-positive pneumonia augments non-small cell lung cancer metastasis via host toll-like receptor 2 activation. Int. J. Cancer Aug 1. 141(3), 561\u2013571 (2017). https:\/\/doi.org\/10.1002\/ijc.30734","journal-title":"Int. J. Cancer Aug 1"},{"issue":"6","key":"1103_CR156","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/ijc.29111","volume":"15","author":"SC Chow","year":"2015","unstructured":"S.C. Chow, S.D. Gowing, J.J. Cools-Lartigue et al., Gram negative bacteria increase non-small cell lung cancer metastasis via Toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation. Int. J. Cancer Mar. 15(6), 1341\u20131350 (2015). https:\/\/doi.org\/10.1002\/ijc.29111","journal-title":"Int. J. Cancer Mar."},{"key":"1103_CR157","doi-asserted-by":"publisher","unstructured":"S.D. Gowing, S.C. Chow, J.J. Cools-Lartigue et al., Dec. Gram-Negative pneumonia augments Non-Small cell lung cancer metastasis through host Toll-like receptor 4 activation. Journal of thoracic oncology : official publication of the international association for the study of lung cancer. 14(12):2097\u20132108 (2019). https:\/\/doi.org\/10.1016\/j.jtho.2019.07.023","DOI":"10.1016\/j.jtho.2019.07.023"},{"issue":"12","key":"1103_CR158","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/ijc.24636","volume":"15","author":"HY Liang","year":"2009","unstructured":"H.Y. Liang, X.L. Li, X.S. Yu et al., Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int. J. Cancer Dec. 15(12), 2936\u20132944 (2009). https:\/\/doi.org\/10.1002\/ijc.24636","journal-title":"Int. J. Cancer Dec."},{"issue":"5","key":"1103_CR159","doi-asserted-by":"publisher","first-page":"151558","DOI":"10.1016\/j.ijmm.2022.151558","volume":"312","author":"AA Malik","year":"2022","unstructured":"A.A. Malik, J.A. Sheikh, N.Z. Ehtesham, S. Hira, S.E. Hasnain, Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in Understanding TB and cancer. Int. J. Med. Microbiol. : IJMM Jul. 312(5), 151558 (2022). https:\/\/doi.org\/10.1016\/j.ijmm.2022.151558","journal-title":"Int. J. Med. Microbiol. : IJMM Jul"},{"issue":"1","key":"1103_CR160","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1423-0127-18-68","volume":"10","author":"TB Tsay","year":"2011","unstructured":"T.B. Tsay, M.C. Yang, P.H. Chen, C.M. Hsu, L.W. Chen, Gut flora enhance bacterial clearance in lung through toll-like receptors 4. J. Biomedical Sci. Sep. 10(1), 68 (2011). https:\/\/doi.org\/10.1186\/1423-0127-18-68","journal-title":"J. Biomedical Sci. Sep."},{"issue":"1","key":"1103_CR161","doi-asserted-by":"publisher","first-page":"2361490","DOI":"10.1080\/19490976.2024.2361490","volume":"16","author":"TL Lin","year":"2024","unstructured":"T.L. Lin, Y.L. Kuo, J.H. Lai et al., Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung disease. Gut Microbes Jan-Dec. 16(1), 2361490 (2024). https:\/\/doi.org\/10.1080\/19490976.2024.2361490","journal-title":"Gut Microbes Jan-Dec"},{"issue":"9","key":"1103_CR162","doi-asserted-by":"publisher","first-page":"e1001397","DOI":"10.1371\/journal.pbio.1001397","volume":"10","author":"JR McGhee","year":"2012","unstructured":"J.R. McGhee, K. Fujihashi, Inside the mucosal immune system. PLoS Biol. 10(9), e1001397 (2012). https:\/\/doi.org\/10.1371\/journal.pbio.1001397","journal-title":"PLoS Biol."},{"issue":"2","key":"1103_CR163","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.smim.2006.10.002","volume":"19","author":"K Smith","year":"2007","unstructured":"K. Smith, K.D. McCoy, A.J. Macpherson, Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Seminars Immunol. Apr. 19(2), 59\u201369 (2007). https:\/\/doi.org\/10.1016\/j.smim.2006.10.002","journal-title":"Seminars Immunol. Apr"},{"key":"1103_CR164","doi-asserted-by":"publisher","unstructured":"Y. Huang, K. Mao, X. Chen et al., S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science (New York, NY). Jan 5. 359(6371):114\u2013119 (2018). https:\/\/doi.org\/10.1126\/science.aam5809","DOI":"10.1126\/science.aam5809"},{"issue":"6","key":"1103_CR165","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"19","author":"O Takeuchi","year":"2010","unstructured":"O. Takeuchi, S. Akira, Pattern recognition receptors and inflammation. Cell. Mar. 19(6), 805\u2013820 (2010). https:\/\/doi.org\/10.1016\/j.cell.2010.01.022","journal-title":"Cell. Mar."},{"issue":"1","key":"1103_CR166","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.immuni.2012.04.011","volume":"27","author":"MC Abt","year":"2012","unstructured":"M.C. Abt, L.C. Osborne, L.A. Monticelli et al., Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immun. Jul. 27(1), 158\u2013170 (2012). https:\/\/doi.org\/10.1016\/j.immuni.2012.04.011","journal-title":"Immun. Jul"},{"issue":"10","key":"1103_CR167","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/embj.201488027","volume":"33","author":"M Dalod","year":"2014","unstructured":"M. Dalod, R. Chelbi, B. Malissen, T. Lawrence, Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming. EMBO J. May 16. 33(10), 1104\u20131116 (2014). https:\/\/doi.org\/10.1002\/embj.201488027","journal-title":"EMBO J. May 16"},{"key":"1103_CR168","doi-asserted-by":"publisher","unstructured":"M. Fukata, M. Arditi, May. The role of pattern recognition receptors in intestinal inflammation. Mucosal immunology. 6(3):451\u2013463 (2013). https:\/\/doi.org\/10.1038\/mi.2013.13","DOI":"10.1038\/mi.2013.13"},{"issue":"6649","key":"1103_CR169","doi-asserted-by":"publisher","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","volume":"9","author":"M Fidelle","year":"2023","unstructured":"M. Fidelle, C. Rauber, C. Alves Costa Silva et al., A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Sci. (New York NY) Jun. 9(6649), eabo2296 (2023). https:\/\/doi.org\/10.1126\/science.abo2296","journal-title":"Sci. (New York NY) Jun"},{"issue":"84","key":"1103_CR170","doi-asserted-by":"publisher","first-page":"eadg8841","DOI":"10.1126\/sciimmunol.adg8841","volume":"2","author":"V Feliu","year":"2023","unstructured":"V. Feliu, C. Gomez-Roca, M. Michelas et al., Distant antimetastatic effect of enterotropic colon cancer-derived \u03b14\u03b27(+)CD8(+) T cells. Sci. Immunol. Jun. 2(84), eadg8841 (2023). https:\/\/doi.org\/10.1126\/sciimmunol.adg8841","journal-title":"Sci. Immunol. Jun"},{"issue":"1","key":"1103_CR171","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1186\/s13054-020-03320-8","volume":"15","author":"R Dessein","year":"2020","unstructured":"R. Dessein, M. Bauduin, T. Grandjean et al., Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice. Critical care (London, England). Oct. 15(1), 611 (2020). https:\/\/doi.org\/10.1186\/s13054-020-03320-8","journal-title":"Oct"},{"key":"1103_CR172","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2019.01142","volume":"10","author":"S Negi","year":"2019","unstructured":"S. Negi, S. Pahari, H. Bashir, J.N. Agrewala, Gut microbiota regulates mincle mediated activation of lung dendritic cells to protect against Mycobacterium tuberculosis. Front. Immunol. 10, 1142 (2019). https:\/\/doi.org\/10.3389\/fimmu.2019.01142","journal-title":"Front. Immunol."},{"key":"1103_CR173","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.intimp.2017.09.024","volume":"52","author":"QY Ma","year":"2017","unstructured":"Q.Y. Ma, D.Y. Huang, H.J. Zhang, S. Wang, X.F. Chen, Upregulation of bacterial-specific Th1 and Th17 responses that are enriched in CXCR5(+)CD4(+) T cells in non-small cell lung cancer. Int. Immunopharmacol. Nov. 52, 305\u2013309 (2017). https:\/\/doi.org\/10.1016\/j.intimp.2017.09.024","journal-title":"Int. Immunopharmacol. Nov"},{"issue":"5","key":"1103_CR174","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.7150\/ijms.107026","volume":"22","author":"H Wang","year":"2025","unstructured":"H. Wang, J. Hu, Y. Ma, Y. Abulimiti, Y. Zhou, Lung commensal bacteria promote lung cancer progression through NK cell-mediated immunosuppressive microenvironment. Int. J. Med. Sci. 22(5), 1039\u20131051 (2025). https:\/\/doi.org\/10.7150\/ijms.107026","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"1103_CR175","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00430-025-00819-1","volume":"13","author":"A Chen","year":"2025","unstructured":"A. Chen, Q. Yu, L. Zheng et al., Dose-dependent M2 macrophage polarization induced by talaromyces Marneffei promotes lung cancer cell growth via arginine-ornithine-cycle activation. Med. Microbiol. Immunol. Feb. 13(1), 11 (2025). https:\/\/doi.org\/10.1007\/s00430-025-00819-1","journal-title":"Med. Microbiol. Immunol. Feb"},{"key":"1103_CR176","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/ncomms3106","volume":"4","author":"J Wang","year":"2013","unstructured":"J. Wang, F. Li, R. Sun et al., Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages. Nat. Commun. 4, 2106 (2013). https:\/\/doi.org\/10.1038\/ncomms3106","journal-title":"Nat. Commun."},{"key":"1103_CR177","doi-asserted-by":"publisher","first-page":"10651","DOI":"10.2147\/ott.S263976","volume":"13","author":"Y Hu","year":"2020","unstructured":"Y. Hu, S. Ren, Y. He et al., Possible oncogenic viruses associated with lung cancer. OncoTargets Therapy. 13, 10651\u201310666 (2020). https:\/\/doi.org\/10.2147\/ott.S263976","journal-title":"OncoTargets Therapy"},{"issue":"4","key":"1103_CR178","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jiph.2023.02.014","volume":"16","author":"AAA Oyouni","year":"2023","unstructured":"A.A.A. Oyouni, Human papillomavirus in cancer: infection, disease transmission, and progress in vaccines. J. Infect. Public. Health Apr. 16(4), 626\u2013631 (2023). https:\/\/doi.org\/10.1016\/j.jiph.2023.02.014","journal-title":"J. Infect. Public. Health Apr"},{"key":"1103_CR179","unstructured":"B.V. Branica, S. Smojver-Jezek, Z. Juros et al., Mar. Detection of human papillomaviruses type 16, 18 and 33 in bronchial aspirates of lung carcinoma patients by polymerase chain reaction: a study of 84 cases in croatia. Collegium antropologicum. 34(1):159\u2013162 (2010)."},{"key":"1103_CR180","doi-asserted-by":"publisher","first-page":"107272","DOI":"10.1016\/j.intimp.2020.107272","volume":"91","author":"J Tang","year":"2021","unstructured":"J. Tang, L. Xu, Y. Zeng, F. Gong, Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4\/NF-kB signaling pathway. Int. Immunopharmacol. Feb. 91, 107272 (2021). https:\/\/doi.org\/10.1016\/j.intimp.2020.107272","journal-title":"Int. Immunopharmacol. Feb"},{"issue":"1","key":"1103_CR181","doi-asserted-by":"publisher","first-page":"1788891","DOI":"10.1080\/19490976.2020.1788891","volume":"9","author":"Z Zhu","year":"2020","unstructured":"Z. Zhu, J. Huang, X. Li et al., Gut microbiota regulate tumor metastasis via circrna\/mirna networks. Gut Microbes Nov. 9(1), 1788891 (2020). https:\/\/doi.org\/10.1080\/19490976.2020.1788891","journal-title":"Gut Microbes Nov"},{"key":"1103_CR182","doi-asserted-by":"publisher","first-page":"1046226","DOI":"10.3389\/fmicb.2022.1046226","volume":"13","author":"X Song","year":"2022","unstructured":"X. Song, B. Liu, G. Zhao et al., Streptococcus pneumoniae promotes migration and invasion of A549 cells in vitro by activating mTORC2\/AKT through up-regulation of DDIT4 expression. Front. Microbiol. 13, 1046226 (2022). https:\/\/doi.org\/10.3389\/fmicb.2022.1046226","journal-title":"Front. Microbiol."},{"issue":"7","key":"1103_CR183","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.chom.2025.06.013","volume":"9","author":"H Yu","year":"2025","unstructured":"H. Yu, Y. Du, Y. He et al., Lactate production by tumor-resident Staphylococcus promotes metastatic colonization in lung adenocarcinoma. Cell host & microbe. Jul. 9(7), 1089\u20131105e7 (2025). https:\/\/doi.org\/10.1016\/j.chom.2025.06.013","journal-title":"Jul"},{"issue":"11","key":"1103_CR184","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.7150\/thno.43108","volume":"10","author":"HH Yang","year":"2020","unstructured":"H.H. Yang, J.X. Duan, S.K. Liu et al., A COX-2\/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics. 10(11), 4749\u20134761 (2020). https:\/\/doi.org\/10.7150\/thno.43108","journal-title":"Theranostics"},{"key":"1103_CR185","doi-asserted-by":"publisher","unstructured":"G. Tezcan, M. Alsaadi, S. Hamza et al., Azithromycin and ceftriaxone differentially activate NLRP3 in LPS primed cancer cells. Int. J. Mol. Sci. Aug. 22(16) (2022). https:\/\/doi.org\/10.3390\/ijms23169484","DOI":"10.3390\/ijms23169484"},{"issue":"3","key":"1103_CR186","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbrc.2015.03.096","volume":"460","author":"S Nakashima","year":"2015","unstructured":"S. Nakashima, T. Kakugawa, H. Yura et al., Identification of Helicobacter pylori VacA in human lung and its effects on lung cells. Biochemical and biophysical research communications. May 8. 460(3), 721\u2013726 (2015). https:\/\/doi.org\/10.1016\/j.bbrc.2015.03.096","journal-title":"May 8"},{"issue":"8","key":"1103_CR187","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1017\/s0007114515002780","volume":"28","author":"N Eid","year":"2015","unstructured":"N. Eid, H. Osmanova, C. Natchez et al., Impact of palm date consumption on microbiota growth and large intestinal health: a randomised, controlled, cross-over, human intervention study. Br. J. Nutr. Oct. 28(8), 1226\u20131236 (2015). https:\/\/doi.org\/10.1017\/s0007114515002780","journal-title":"Br. J. Nutr. Oct."},{"issue":"4","key":"1103_CR188","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1039\/c5fo01276g","volume":"7","author":"K Vipperla","year":"2016","unstructured":"K. Vipperla, S.J. O\u2019Keefe, Diet, microbiota, and dysbiosis: a \u2018recipe\u2019 for colorectal cancer. Food Function Apr. 7(4), 1731\u20131740 (2016). https:\/\/doi.org\/10.1039\/c5fo01276g","journal-title":"Food Function Apr"},{"issue":"12","key":"1103_CR189","first-page":"3288","volume":"15","author":"BG Heerdt","year":"1994","unstructured":"B.G. Heerdt, M.A. Houston, L.H. Augenlicht, Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. Jun. 15(12), 3288\u20133293 (1994)","journal-title":"Cancer Res. Jun"},{"key":"1103_CR190","doi-asserted-by":"publisher","first-page":"590685","DOI":"10.3389\/fimmu.2020.590685","volume":"11","author":"Q Yang","year":"2020","unstructured":"Q. Yang, J. Ouyang, F. Sun, J. Yang, Short-Chain fatty acids: A soldier fighting against inflammation and protecting from tumorigenesis in people with diabetes. Front. Immunol. 11, 590685 (2020). https:\/\/doi.org\/10.3389\/fimmu.2020.590685","journal-title":"Front. Immunol."},{"issue":"1","key":"1103_CR191","doi-asserted-by":"publisher","first-page":"10887","DOI":"10.1038\/s41598-020-67843-4","volume":"2","author":"K Allers","year":"2020","unstructured":"K. Allers, C. Stahl-Hennig, T. Fiedler et al., The colonic mucosa-associated Microbiome in SIV infection: shift towards bacteroidetes coincides with mucosal CD4(+) T cell depletion and enterocyte damage. Sci. Rep. Jul. 2(1), 10887 (2020). https:\/\/doi.org\/10.1038\/s41598-020-67843-4","journal-title":"Sci. Rep. Jul"},{"key":"1103_CR192","doi-asserted-by":"publisher","unstructured":"A. Botticelli, P. Vernocchi, F. Marini et al., Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment. Journal of translational medicine. 18(1):49 (Feb 3. 2020). https:\/\/doi.org\/10.1186\/s12967-020-02231-0","DOI":"10.1186\/s12967-020-02231-0"},{"issue":"1","key":"1103_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"M. Sun, W. Wu, Z. Liu, Y. Cong, Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J. Gastroenterol. Jan. 52(1), 1\u20138 (2017). https:\/\/doi.org\/10.1007\/s00535-016-1242-9","journal-title":"J. Gastroenterol. Jan"},{"issue":"4","key":"1103_CR194","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cmet.2017.03.008","volume":"4","author":"AS Husted","year":"2017","unstructured":"A.S. Husted, M. Trauelsen, O. Rudenko, S.A. Hjorth, T.W. Schwartz, GPCR-Mediated signaling of metabolites. Cell metabolism. Apr. 4(4), 777\u2013796 (2017). https:\/\/doi.org\/10.1016\/j.cmet.2017.03.008","journal-title":"Apr"},{"key":"1103_CR195","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","volume":"6","author":"L Macia","year":"2015","unstructured":"L. Macia, J. Tan, A.T. Vieira et al., Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. Apr 1. 6, 6734 (2015). https:\/\/doi.org\/10.1038\/ncomms7734","journal-title":"Nat. Commun. Apr 1"},{"key":"1103_CR196","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.conb.2019.09.016","volume":"62","author":"SN Peterson","year":"2020","unstructured":"S.N. Peterson, L.M. Bradley, Z.A. Ronai, The gut microbiome: an unexpected player in cancer immunity. Current opinion in neurobiology. Jun. 62, 48\u201352 (2020). https:\/\/doi.org\/10.1016\/j.conb.2019.09.016","journal-title":"Jun"},{"issue":"1\u20132","key":"1103_CR197","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11010-005-9054-x","volume":"285","author":"YF Wang","year":"2006","unstructured":"Y.F. Wang, N.S. Chen, Y.P. Chung, L.H. Chang, Y.H. Chiou, C.Y. Chen, Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1\/WAF1) induction. Molecular and cellular biochemistry. Apr. 285(1\u20132), 51\u201359 (2006). https:\/\/doi.org\/10.1007\/s11010-005-9054-x","journal-title":"Apr"},{"issue":"30","key":"1103_CR198","doi-asserted-by":"publisher","first-page":"21040","DOI":"10.1074\/jbc.M511059200","volume":"28","author":"MV Abramova","year":"2006","unstructured":"M.V. Abramova, T.V. Pospelova, F.P. Nikulenkov, C.M. Hollander, A.J. Jr. Fornace, V.A. Pospelov, G1\/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of beta-catenin. J. Biol. Chem. Jul. 28(30), 21040\u201321051 (2006). https:\/\/doi.org\/10.1074\/jbc.M511059200","journal-title":"J. Biol. Chem. Jul"},{"issue":"12","key":"1103_CR199","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.4161\/cc.10.12.15825","volume":"15","author":"V Edmond","year":"2011","unstructured":"V. Edmond, C. Brambilla, E. Brambilla, S. Gazzeri, B. Eymin, SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines. Cell. Cycle (Georgetown Tex) Jun. 15(12), 1968\u20131977 (2011). https:\/\/doi.org\/10.4161\/cc.10.12.15825","journal-title":"Cell. Cycle (Georgetown Tex) Jun"},{"issue":"4","key":"1103_CR200","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1002\/jcb.26547","volume":"119","author":"X Xiao","year":"2018","unstructured":"X. Xiao, Y. Cao, H. Chen, Profiling and characterization of MicroRNAs responding to sodium butyrate treatment in A549 cells. J. Cell. Biochem. Apr. 119(4), 3563\u20133573 (2018). https:\/\/doi.org\/10.1002\/jcb.26547","journal-title":"J. Cell. Biochem. Apr"},{"issue":"4","key":"1103_CR201","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s42255-022-00553-5","volume":"4","author":"AP Gomes","year":"2022","unstructured":"A.P. Gomes, D. Ilter, V. Low et al., Altered propionate metabolism contributes to tumour progression and aggressiveness. Nat. Metabolism Apr. 4(4), 435\u2013443 (2022). https:\/\/doi.org\/10.1038\/s42255-022-00553-5","journal-title":"Nat. Metabolism Apr"},{"key":"1103_CR202","doi-asserted-by":"publisher","first-page":"105150","DOI":"10.1016\/j.phrs.2020.105150","volume":"161","author":"Y Wang","year":"2020","unstructured":"Y. Wang, Y. Wu, J. Sailike et al., Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1\/M2 phenotype macrophage in db\/db mice. Pharmacol. Res. Nov. 161, 105150 (2020). https:\/\/doi.org\/10.1016\/j.phrs.2020.105150","journal-title":"Pharmacol. Res. Nov"},{"issue":"5","key":"1103_CR203","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1172\/jci31537","volume":"117","author":"WW Lin","year":"2007","unstructured":"W.W. Lin, M. Karin, A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. May. 117(5), 1175\u20131183 (2007). https:\/\/doi.org\/10.1172\/jci31537","journal-title":"J. Clin. Invest. May"},{"issue":"22","key":"1103_CR204","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.1158\/1078-0432.Ccr-13-3203","volume":"15","author":"MF Sanmamed","year":"2014","unstructured":"M.F. Sanmamed, O. Carranza-Rua, C. Alfaro et al., Serum interleukin-8 reflects tumor burden and treatment response across malignancies of multiple tissue origins. Clin. Cancer Res. : Official J. Am. Association Cancer Res. Nov. 15(22), 5697\u20135707 (2014). https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-3203","journal-title":"Clin. Cancer Res. : Official J. Am. Association Cancer Res. Nov"},{"issue":"5","key":"1103_CR205","doi-asserted-by":"publisher","first-page":"e10667","DOI":"10.1371\/journal.pone.0010667","volume":"17","author":"E Biagi","year":"2010","unstructured":"E. Biagi, L. Nylund, M. Candela et al., Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PloS One May. 17(5), e10667 (2010). https:\/\/doi.org\/10.1371\/journal.pone.0010667","journal-title":"PloS One May"},{"key":"1103_CR206","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.3389\/fmicb.2019.01206","volume":"10","author":"R El Hage","year":"2019","unstructured":"El R. Hage, E. Hernandez-Sanabria, M. Calatayud Arroyo, R. Van de Props, Propionate-Producing consortium restores Antibiotic-Induced dysbiosis in a dynamic in vitro model of the human intestinal microbial ecosystem. Front. Microbiol. 10, 1206 (2019). https:\/\/doi.org\/10.3389\/fmicb.2019.01206","journal-title":"Front. Microbiol."},{"key":"1103_CR207","doi-asserted-by":"publisher","first-page":"658354","DOI":"10.3389\/fimmu.2021.658354","volume":"12","author":"N Gasaly","year":"2021","unstructured":"N. Gasaly, de P. Vos, M.A. Hermoso, Impact of bacterial metabolites on gut barrier function and host immunity: A focus on bacterial metabolism and its relevance for intestinal inflammation. Front. Immunol. 12, 658354 (2021). https:\/\/doi.org\/10.3389\/fimmu.2021.658354","journal-title":"Front. Immunol."},{"issue":"15","key":"1103_CR208","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/0008-5472.Can-20-4090","volume":"1","author":"M Matsushita","year":"2021","unstructured":"M. Matsushita, K. Fujita, T. Hayashi et al., Gut Microbiota-Derived Short-Chain fatty acids promote prostate cancer growth via IGF1 signaling. Cancer Res. Aug. 1(15), 4014\u20134026 (2021). https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4090","journal-title":"Cancer Res. Aug"},{"issue":"12","key":"1103_CR209","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.7150\/ijbs.62573","volume":"17","author":"J Yang","year":"2021","unstructured":"J. Yang, M. Qi, X. Fei, X. Wang, K. Wang, LncRNA H19: A novel oncogene in multiple cancers. Int. J. Biol. Sci. 17(12), 3188\u20133208 (2021). https:\/\/doi.org\/10.7150\/ijbs.62573","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"1103_CR210","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1002\/jcsm.12804","volume":"12","author":"J Ubachs","year":"2021","unstructured":"J. Ubachs, J. Ziemons, Z. Soons et al., Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients. J. Cachexia Sarcopenia Muscle Dec. 12(6), 2007\u20132021 (2021). https:\/\/doi.org\/10.1002\/jcsm.12804","journal-title":"J. Cachexia Sarcopenia Muscle Dec."},{"key":"1103_CR211","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3389\/fmicb.2018.01757","volume":"9","author":"PL Apopa","year":"2018","unstructured":"P.L. Apopa, L. Alley, R.B. Penney et al., PARP1 is Up-Regulated in Non-small cell lung cancer tissues in the presence of the cyanobacterial toxin microcystin. Front. Microbiol. 9, 1757 (2018). https:\/\/doi.org\/10.3389\/fmicb.2018.01757","journal-title":"Front. Microbiol."},{"issue":"2","key":"1103_CR212","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-010-1085-7","volume":"128","author":"M Koch","year":"2011","unstructured":"M. Koch, F. Hussein, A. Woeste et al., CD36-mediated activation of endothelial cell apoptosis by an N-terminal Recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res. Treat. Jul. 128(2), 337\u2013346 (2011). https:\/\/doi.org\/10.1007\/s10549-010-1085-7","journal-title":"Breast Cancer Res. Treat. Jul"},{"issue":"6","key":"1103_CR213","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s13402-023-00832-7","volume":"46","author":"AA Vega","year":"2023","unstructured":"A.A. Vega, E.A. Marshall, A.J.C. Noonan et al., Methionine-producing tumor micro(be) environment fuels growth of solid tumors. Cell. Oncol. (Dordrecht) Dec. 46(6), 1659\u20131673 (2023). https:\/\/doi.org\/10.1007\/s13402-023-00832-7","journal-title":"Cell. Oncol. (Dordrecht) Dec."},{"issue":"1","key":"1103_CR214","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1186\/s12967-025-06701-1","volume":"17","author":"L Gao","year":"2025","unstructured":"L. Gao, H. Liao, Y. Chen et al., Airway microbiota associated D-phenylalanine promotes non-small cell lung cancer metastasis through epithelial mesenchymal transition. J. Translational Med. Jun. 17(1), 673 (2025). https:\/\/doi.org\/10.1186\/s12967-025-06701-1","journal-title":"J. Translational Med. Jun"},{"key":"1103_CR215","doi-asserted-by":"publisher","unstructured":"S. Viaud, F. Saccheri, G. Mignot et al., The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, NY). 342(6161):971-6 (Nov 22. 2013). https:\/\/doi.org\/10.1126\/science.1240537","DOI":"10.1126\/science.1240537"},{"issue":"6","key":"1103_CR216","doi-asserted-by":"publisher","first-page":"e1150399","DOI":"10.1080\/2162402x.2016.1150399","volume":"5","author":"N Pflug","year":"2016","unstructured":"N. Pflug, S. Kluth, J.J. Vehreschild et al., Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota. Oncoimmunology Jun. 5(6), e1150399 (2016). https:\/\/doi.org\/10.1080\/2162402x.2016.1150399","journal-title":"Oncoimmunology Jun"},{"issue":"2","key":"1103_CR217","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.4238\/2015.May.25.16","volume":"25","author":"QF Gui","year":"2015","unstructured":"Q.F. Gui, H.F. Lu, C.X. Zhang, Z.R. Xu, Y.H. Yang, Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model. Genet. Mol. Res. : GMR May. 25(2), 5642\u20135651 (2015). https:\/\/doi.org\/10.4238\/2015.May.25.16","journal-title":"Genet. Mol. Res. : GMR May"},{"issue":"6161","key":"1103_CR218","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1240527","volume":"22","author":"N Iida","year":"2013","unstructured":"N. Iida, A. Dzutsev, C.A. Stewart et al., Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Sci. (New York NY) Nov. 22(6161), 967\u2013970 (2013). https:\/\/doi.org\/10.1126\/science.1240527","journal-title":"Sci. (New York NY) Nov"},{"issue":"1","key":"1103_CR219","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-020-65792-6","volume":"4","author":"C Pensec","year":"2020","unstructured":"C. Pensec, F. Gillaizeau, D. Guenot et al., Impact of pemetrexed chemotherapy on the gut microbiota and intestinal inflammation of patient-lung-derived tumor xenograft (PDX) mouse models. Sci. Rep. Jun. 4(1), 9094 (2020). https:\/\/doi.org\/10.1038\/s41598-020-65792-6","journal-title":"Sci. Rep. Jun"},{"issue":"4","key":"1103_CR220","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.immuni.2016.09.009","volume":"18","author":"R Daill\u00e8re","year":"2016","unstructured":"R. Daill\u00e8re, M. V\u00e9tizou, N. Waldschmitt et al., Enterococcus Hirae and Barnesiella intestinihominis facilitate Cyclophosphamide-Induced therapeutic Immunomodulatory effects. Immun. Oct. 18(4), 931\u2013943 (2016). https:\/\/doi.org\/10.1016\/j.immuni.2016.09.009","journal-title":"Immun. Oct."},{"key":"1103_CR221","doi-asserted-by":"publisher","first-page":"2969287","DOI":"10.1155\/2020\/2969287","volume":"2020","author":"Z Chen","year":"2020","unstructured":"Z. Chen, X. Qian, S. Chen, X. Fu, G. Ma, A. Zhang, Akkermansia muciniphila enhances the antitumor effect of cisplatin in Lewis lung cancer mice. J. Immunol. Res. 2020, 2969287 (2020). https:\/\/doi.org\/10.1155\/2020\/2969287","journal-title":"J. Immunol. Res."},{"key":"1103_CR222","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jconrel.2020.07.009","volume":"326","author":"Z Cao","year":"2020","unstructured":"Z. Cao, J. Liu, Bacteria and bacterial derivatives as drug carriers for cancer therapy. J. Controlled Release : Official J. Controlled Release Soc. Oct. 10. 326, 396\u2013407 (2020). https:\/\/doi.org\/10.1016\/j.jconrel.2020.07.009","journal-title":"J. Controlled Release : Official J. Controlled Release Soc. Oct. 10"},{"issue":"5","key":"1103_CR223","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1128\/iai.66.5.1934-1940.1998","volume":"66","author":"CA Whitehouse","year":"1998","unstructured":"C.A. Whitehouse, P.B. Balbo, E.C. Pesci, D.L. Cottle, P.M. Mirabito, C.L. Pickett, Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect. Immun. May. 66(5), 1934\u20131940 (1998). https:\/\/doi.org\/10.1128\/iai.66.5.1934-1940.1998","journal-title":"Infect. Immun. May"},{"key":"1103_CR224","doi-asserted-by":"publisher","unstructured":"Y.A. Chen, Y.R. Lai, H.Y. Wu et al., Bacterial Genotoxin-Coated nanoparticles for radiotherapy sensitization in prostate cancer. Biomedicines Feb. 4(2) (2021). https:\/\/doi.org\/10.3390\/biomedicines9020151","DOI":"10.3390\/biomedicines9020151"},{"key":"1103_CR225","doi-asserted-by":"publisher","unstructured":"S.N. Wai, B. Lindmark, T. S\u00f6derblom et al., Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell. 115(1):25\u201335 (Oct 3. 2003). https:\/\/doi.org\/10.1016\/s0092-86740300754-2","DOI":"10.1016\/s0092-86740300754-2"},{"issue":"1","key":"1103_CR226","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40168-020-00845-6","volume":"20","author":"HW Xiao","year":"2020","unstructured":"H.W. Xiao, M. Cui, Y. Li et al., Gut microbiota-derived Indole 3-propionic acid protects against radiation toxicity via retaining acyl-CoA-binding protein. Microbiome May. 20(1), 69 (2020). https:\/\/doi.org\/10.1186\/s40168-020-00845-6","journal-title":"Microbiome May"},{"key":"1103_CR227","doi-asserted-by":"publisher","unstructured":"Z.Y. Chen, H.W. Xiao, J.L. Dong et al., Gut Microbiota-Derived PGF2\u03b1 fights against Radiation-Induced lung toxicity through the MAPK\/NF-\u03baB pathway. Antioxidants (Basel, Switzerland). Dec. 28(1) (2021). https:\/\/doi.org\/10.3390\/antiox11010065","DOI":"10.3390\/antiox11010065"},{"key":"1103_CR228","doi-asserted-by":"publisher","unstructured":"E.H. Bernicker, E.M.M. Quigley, Aug. The gut Microbiome influences responses to programmed death 1 therapy in Chinese lung cancer Patients - the benefits of diversity. Journal of thoracic oncology : official publication of the international association for the study of lung cancer. 14(8):1319\u20131322 (2019). https:\/\/doi.org\/10.1016\/j.jtho.2019.05.016","DOI":"10.1016\/j.jtho.2019.05.016"},{"issue":"11","key":"1103_CR229","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"13","author":"LE Colbert","year":"2023","unstructured":"L.E. Colbert, El M.B. Alam, R. Wang et al., Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. Nov. 13(11), 1945\u20131962e11 (2023). https:\/\/doi.org\/10.1016\/j.ccell.2023.09.012","journal-title":"Cancer Cell. Nov"},{"issue":"2","key":"1103_CR230","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.09.019","volume":"5","author":"B Faubert","year":"2017","unstructured":"B. Faubert, K.Y. Li, L. Cai et al., Lactate metabolism in human lung tumors. Cell. Oct. 5(2), 358\u2013371e9 (2017). https:\/\/doi.org\/10.1016\/j.cell.2017.09.019","journal-title":"Cell. Oct."},{"issue":"2","key":"1103_CR231","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijrobp.2022.07.032","volume":"1","author":"B Qiu","year":"2023","unstructured":"B. Qiu, Y. Xi, F. Liu et al., Gut Microbiome is associated with the response to chemoradiotherapy in patients with Non-small cell lung cancer. Int. J. Radiation Oncol. Biology Phys. Feb. 1(2), 407\u2013418 (2023). https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.032","journal-title":"Int. J. Radiation Oncol. Biology Phys. Feb"},{"issue":"1","key":"1103_CR232","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40164-024-00478-7","volume":"9","author":"T Jiang","year":"2024","unstructured":"T. Jiang, M. Zhang, S. Hao, S. Huang, X. Zheng, Z. Sun, Revealing the role of the gut microbiota in enhancing targeted therapy efficacy for lung adenocarcinoma. Experimental Hematol. Oncol. Feb. 9(1), 15 (2024). https:\/\/doi.org\/10.1186\/s40164-024-00478-7","journal-title":"Experimental Hematol. Oncol. Feb"},{"key":"1103_CR233","doi-asserted-by":"publisher","first-page":"113081","DOI":"10.1016\/j.biopha.2022.113081","volume":"151","author":"B Cao","year":"2022","unstructured":"B. Cao, S. Wang, R. Li et al., Xihuang pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway. Biomed. pharmacotherapy = Biomedecine Pharmacotherapie Jul. 151, 113081 (2022). https:\/\/doi.org\/10.1016\/j.biopha.2022.113081","journal-title":"Biomed. pharmacotherapy = Biomedecine Pharmacotherapie Jul"},{"key":"1103_CR234","doi-asserted-by":"publisher","unstructured":"V. Gopalakrishnan, C.N. Spencer, L. Nezi et al., Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science (New York, NY). Jan 5. 359(6371):97\u2013103 (2018). https:\/\/doi.org\/10.1126\/science.aan4236","DOI":"10.1126\/science.aan4236"},{"key":"1103_CR235","doi-asserted-by":"publisher","unstructured":"B. Routy, Le E. Chatelier, L. Derosa et al., Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, NY). Jan 5. 359(6371):91\u201397 (2018). https:\/\/doi.org\/10.1126\/science.aan3706","DOI":"10.1126\/science.aan3706"},{"key":"1103_CR236","doi-asserted-by":"publisher","unstructured":"V. Matson, J. Fessler, R. Bao et al., The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science (New York, NY). Jan 5. 359(6371):104\u2013108 (2018). https:\/\/doi.org\/10.1126\/science.aao3290","DOI":"10.1126\/science.aao3290"},{"issue":"8","key":"1103_CR237","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","volume":"14","author":"Y Jin","year":"2019","unstructured":"Y. Jin, H. Dong, L. Xia et al., The diversity of gut Microbiome is associated with favorable responses to Anti-Programmed death 1 immunotherapy in Chinese patients with NSCLC. Journal of thoracic oncology : official publication of the international association for the study of lung cancer. Aug. 14(8), 1378\u20131389 (2019). https:\/\/doi.org\/10.1016\/j.jtho.2019.04.007","journal-title":"Aug"},{"issue":"2","key":"1103_CR238","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s40487-021-00171-3","volume":"9","author":"D He","year":"2021","unstructured":"D. He, X. Li, R. An et al., Response to PD-1-Based immunotherapy for Non-Small cell lung cancer altered by gut microbiota. Oncology and therapy. Dec. 9(2), 647\u2013657 (2021). https:\/\/doi.org\/10.1007\/s40487-021-00171-3","journal-title":"Dec"},{"issue":"4","key":"1103_CR239","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","volume":"71","author":"J Huang","year":"2022","unstructured":"J. Huang, D. Liu, Y. Wang et al., Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy. Gut Apr. 71(4), 734\u2013745 (2022). https:\/\/doi.org\/10.1136\/gutjnl-2020-321031","journal-title":"Gut Apr"},{"issue":"1","key":"1103_CR240","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jgr.2022.07.002","volume":"47","author":"R Tao","year":"2023","unstructured":"R. Tao, K. Lu, G. Zong et al., Ginseng polysaccharides: potential antitumor agents. J. Ginseng Res. Jan. 47(1), 9\u201322 (2023). https:\/\/doi.org\/10.1016\/j.jgr.2022.07.002","journal-title":"J. Ginseng Res. Jan"},{"key":"1103_CR241","doi-asserted-by":"publisher","unstructured":"M. V\u00e9tizou, J.M. Pitt, R. Daill\u00e8re et al., Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, NY). Nov 27. 350(6264):1079-84 (2015). https:\/\/doi.org\/10.1126\/science.aad1329","DOI":"10.1126\/science.aad1329"},{"key":"1103_CR242","doi-asserted-by":"publisher","unstructured":"R. Preet, M.A. Islam, J. Shim et al., Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer. Nature communications. 16(1):3500 (Apr 12. 2025). https:\/\/doi.org\/10.1038\/s41467-025-58553-4","DOI":"10.1038\/s41467-025-58553-4"},{"issue":"4","key":"1103_CR243","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/0008-5472.Can-10-2238","volume":"15","author":"MP Chao","year":"2011","unstructured":"M.P. Chao, A.A. Alizadeh, C. Tang et al., Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. Cancer Res. Feb. 15(4), 1374\u20131384 (2011). https:\/\/doi.org\/10.1158\/0008-5472.Can-10-2238","journal-title":"Cancer Res. Feb"},{"key":"1103_CR244","doi-asserted-by":"publisher","unstructured":"A. Sivan, L. Corrales, N. Hubert et al., Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science (New York, NY). 350(6264):1084-9 (Nov 27. 2015). https:\/\/doi.org\/10.1126\/science.aac4255","DOI":"10.1126\/science.aac4255"},{"key":"1103_CR245","doi-asserted-by":"publisher","unstructured":"Y. Shi, W. Zheng, K. Yang et al., Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J. Experimental Med. May. 4(5) (2020). https:\/\/doi.org\/10.1084\/jem.20192282","DOI":"10.1084\/jem.20192282"},{"key":"1103_CR246","doi-asserted-by":"publisher","unstructured":"C.A. Bessell, A. Isser, J.J. Havel et al., Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight Apr. 23(8) (2020). https:\/\/doi.org\/10.1172\/jci.insight.135597","DOI":"10.1172\/jci.insight.135597"},{"issue":"3","key":"1103_CR247","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41564-020-00831-6","volume":"6","author":"SH Lee","year":"2021","unstructured":"S.H. Lee, S.Y. Cho, Y. Yoon et al., Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nat. Microbiol. Mar. 6(3), 277\u2013288 (2021). https:\/\/doi.org\/10.1038\/s41564-020-00831-6","journal-title":"Nat. Microbiol. Mar."},{"key":"1103_CR248","doi-asserted-by":"publisher","unstructured":"Y. Tomita, S. Sakata, K. Imamura et al., Association of clostridium Butyricum therapy using the live bacterial product CBM588 with the survival of patients with lung cancer receiving chemoimmunotherapy combinations. Cancers Dec. 21(1) (2023). https:\/\/doi.org\/10.3390\/cancers16010047","DOI":"10.3390\/cancers16010047"},{"issue":"1","key":"1103_CR249","doi-asserted-by":"publisher","first-page":"2081010","DOI":"10.1080\/2162402x.2022.2081010","volume":"11","author":"Y Tomita","year":"2022","unstructured":"Y. Tomita, Y. Goto, S. Sakata et al., Clostridium Butyricum therapy restores the decreased efficacy of immune checkpoint Blockade in lung cancer patients receiving proton pump inhibitors. Oncoimmunology. 11(1), 2081010 (2022). https:\/\/doi.org\/10.1080\/2162402x.2022.2081010","journal-title":"Oncoimmunology"},{"issue":"5","key":"1103_CR250","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1002\/ijc.35472","volume":"157","author":"K Tajima","year":"2025","unstructured":"K. Tajima, M. Hosonuma, E. Funayama et al., Combination therapy with Levofloxacin and the probiotic clostridium Butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy. Int. J. Cancer Sep. 1. 157(5), 993\u20131005 (2025). https:\/\/doi.org\/10.1002\/ijc.35472","journal-title":"Int. J. Cancer Sep. 1"},{"issue":"1","key":"1103_CR251","doi-asserted-by":"publisher","first-page":"2315631","DOI":"10.1080\/19490976.2024.2315631","volume":"16","author":"T Del Paz","year":"2024","unstructured":"T. Del Paz, K. Oka, O. Boulard et al., The biotherapeutic clostridium Butyricum MIYAIRI 588 strain potentiates enterotropism of Ror\u03b3t(+)Treg and PD-1 Blockade efficacy. Gut microbes. Jan-Dec. 16(1), 2315631 (2024). https:\/\/doi.org\/10.1080\/19490976.2024.2315631","journal-title":"Jan-Dec"},{"issue":"1","key":"1103_CR252","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12931-021-01919-1","volume":"28","author":"HJ Jang","year":"2021","unstructured":"H.J. Jang, J.Y. Choi, K. Kim et al., Relationship of the lung Microbiome with PD-L1 expression and immunotherapy response in lung cancer. Respiratory research. Dec. 28(1), 322 (2021). https:\/\/doi.org\/10.1186\/s12931-021-01919-1","journal-title":"Dec"},{"issue":"6","key":"1103_CR253","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nm.3568","volume":"20","author":"ES Gollwitzer","year":"2014","unstructured":"E.S. Gollwitzer, S. Saglani, A. Trompette et al., Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat. Med. Jun. 20(6), 642\u2013647 (2014). https:\/\/doi.org\/10.1038\/nm.3568","journal-title":"Nat. Med. Jun"},{"key":"1103_CR254","doi-asserted-by":"publisher","unstructured":"J.J. Tsay, B.G. Wu, I. Sulaiman et al., Feb. Lower airway dysbiosis affects lung cancer progression. cancer discovery. 11(2):293\u2013307 (2021). https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-0263","DOI":"10.1158\/2159-8290.Cd-20-0263"},{"issue":"1","key":"1103_CR255","doi-asserted-by":"publisher","first-page":"e70170","DOI":"10.1002\/ctm2.70170","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Y. Zhang, X.X. Chen, R. Chen et al., Lower respiratory tract Microbiome dysbiosis impairs clinical responses to immune checkpoint Blockade in advanced non-small-cell lung cancer. Clin. Translational Med. Jan. 15(1), e70170 (2025). https:\/\/doi.org\/10.1002\/ctm2.70170","journal-title":"Clin. Translational Med. Jan"},{"key":"1103_CR256","doi-asserted-by":"publisher","unstructured":"X.X. Chen, Q. Ju, D. Qiu et al., Microbial dysbiosis with Tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer. Cancer immunology, immunotherapy : CII. 74(4):140 (Mar 8 2025). https:\/\/doi.org\/10.1007\/s00262-025-03996-3","DOI":"10.1007\/s00262-025-03996-3"},{"issue":"2","key":"1103_CR257","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jnci\/djaa057","volume":"1","author":"JJ Mohiuddin","year":"2021","unstructured":"J.J. Mohiuddin, B. Chu, A. Facciabene et al., Association of antibiotic exposure with survival and toxicity in patients with melanoma receiving immunotherapy. J. Natl. Cancer Inst. Feb. 1(2), 162\u2013170 (2021). https:\/\/doi.org\/10.1093\/jnci\/djaa057","journal-title":"J. Natl. Cancer Inst. Feb"},{"key":"1103_CR258","doi-asserted-by":"publisher","unstructured":"Y. Jing, X. Chen, K. Li et al., Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy. J. Immunotherapy Cancer Jan. 10(1) (2022). https:\/\/doi.org\/10.1136\/jitc-2021-003779","DOI":"10.1136\/jitc-2021-003779"},{"key":"1103_CR259","doi-asserted-by":"publisher","first-page":"1001623","DOI":"10.3389\/fimmu.2022.1001623","volume":"13","author":"G Zhou","year":"2022","unstructured":"G. Zhou, N. Zhang, K. Meng, F. Pan, Interaction between gut microbiota and immune checkpoint inhibitor-related colitis. Front. Immunol. 13, 1001623 (2022). https:\/\/doi.org\/10.3389\/fimmu.2022.1001623","journal-title":"Front. Immunol."},{"key":"1103_CR260","doi-asserted-by":"publisher","first-page":"1109281","DOI":"10.3389\/fimmu.2023.1109281","volume":"14","author":"X Liu","year":"2023","unstructured":"X. Liu, H. Tang, Q. Zhou et al., Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events. Front. Immunol. 14, 1109281 (2023). https:\/\/doi.org\/10.3389\/fimmu.2023.1109281","journal-title":"Front. Immunol."},{"key":"1103_CR261","doi-asserted-by":"publisher","first-page":"105427","DOI":"10.1016\/j.ebiom.2024.105427","volume":"109","author":"X Liu","year":"2024","unstructured":"X. Liu, B. Lu, H. Tang et al., Gut Microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors. EBioMedicine Nov. 109, 105427 (2024). https:\/\/doi.org\/10.1016\/j.ebiom.2024.105427","journal-title":"EBioMedicine Nov"},{"issue":"9","key":"1103_CR262","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"25","author":"TW Battaglia","year":"2024","unstructured":"T.W. Battaglia, I.L. Mimpen, J.J.H. Traets et al., A pan-cancer analysis of the Microbiome in metastatic cancer. Cell. Apr. 25(9), 2324\u20132335e19 (2024). https:\/\/doi.org\/10.1016\/j.cell.2024.03.021","journal-title":"Cell. Apr"},{"issue":"7852","key":"1103_CR263","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"S. Kalaora, A. Nagler, D. Nejman et al., Identification of bacteria-derived HLA-bound peptides in melanoma. Nat. Apr. 592(7852), 138\u2013143 (2021). https:\/\/doi.org\/10.1038\/s41586-021-03368-8","journal-title":"Nat. Apr"},{"issue":"3","key":"1103_CR264","doi-asserted-by":"publisher","first-page":"e0111524","DOI":"10.1128\/msystems.01115-24","volume":"18","author":"D Huang","year":"2025","unstructured":"D. Huang, Y. Chen, C. Li et al., Variations in salivary Microbiome and metabolites are associated with immunotherapy efficacy in patients with advanced NSCLC. mSystems Mar. 18(3), e0111524 (2025). https:\/\/doi.org\/10.1128\/msystems.01115-24","journal-title":"mSystems Mar."},{"issue":"8","key":"1103_CR265","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","volume":"11","author":"C Hill","year":"2014","unstructured":"C. Hill, F. Guarner, G. Reid et al., Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Reviews Gastroenterol. Hepatol. Aug. 11(8), 506\u2013514 (2014). https:\/\/doi.org\/10.1038\/nrgastro.2014.66","journal-title":"Nat. Reviews Gastroenterol. Hepatol. Aug"},{"issue":"11","key":"1103_CR266","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","volume":"17","author":"KS Swanson","year":"2020","unstructured":"K.S. Swanson, G.R. Gibson, R. Hutkins et al., The international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Reviews Gastroenterol. Hepatol. Nov. 17(11), 687\u2013701 (2020). https:\/\/doi.org\/10.1038\/s41575-020-0344-2","journal-title":"Nat. Reviews Gastroenterol. Hepatol. Nov"},{"issue":"8","key":"1103_CR267","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"G.R. Gibson, R. Hutkins, M.E. Sanders et al., Expert consensus document: the international scientific association for probiotics and prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Reviews Gastroenterol. Hepatol. Aug. 14(8), 491\u2013502 (2017). https:\/\/doi.org\/10.1038\/nrgastro.2017.75","journal-title":"Nat. Reviews Gastroenterol. Hepatol. Aug"},{"key":"1103_CR268","doi-asserted-by":"publisher","unstructured":"F. Pizzo, Z. Maroccia, I. Hammarberg Ferri, C. Fiorentini, Role of the microbiota in lung cancer: insights on prevention and treatment. Int. J. Mol. Sci. May. 30(11) (2022). https:\/\/doi.org\/10.3390\/ijms23116138","DOI":"10.3390\/ijms23116138"},{"issue":"6","key":"1103_CR269","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","volume":"15","author":"B Routy","year":"2018","unstructured":"B. Routy, V. Gopalakrishnan, R. Daill\u00e8re, L. Zitvogel, J.A. Wargo, G. Kroemer, The gut microbiota influences anticancer immunosurveillance and general health. Nat. Reviews Clin. Oncol. Jun. 15(6), 382\u2013396 (2018). https:\/\/doi.org\/10.1038\/s41571-018-0006-2","journal-title":"Nat. Reviews Clin. Oncol. Jun"},{"issue":"10","key":"1103_CR270","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.Cir-20-0051","volume":"8","author":"Y Tomita","year":"2020","unstructured":"Y. Tomita, T. Ikeda, S. Sakata et al., Association of probiotic clostridium Butyricum therapy with survival and response to immune checkpoint Blockade in patients with lung cancer. Cancer Immunol. Res. Oct. 8(10), 1236\u20131242 (2020). https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0051","journal-title":"Cancer Immunol. Res. Oct."},{"issue":"7637","key":"1103_CR271","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"18","author":"DS Chen","year":"2017","unstructured":"D.S. Chen, I. Mellman, Elements of cancer immunity and the cancer-immune set point. Nat. Jan. 18(7637), 321\u2013330 (2017). https:\/\/doi.org\/10.1038\/nature21349","journal-title":"Nat. Jan"},{"key":"1103_CR272","doi-asserted-by":"publisher","unstructured":"E.N. Baruch, I. Youngster, G. Ben-Betzalel et al., Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science (New York, NY). 371(6529):602\u2013609 (Feb 5. 2021). https:\/\/doi.org\/10.1126\/science.abb5920","DOI":"10.1126\/science.abb5920"},{"issue":"7","key":"1103_CR273","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.2604","volume":"14","author":"Y Belkaid","year":"2013","unstructured":"Y. Belkaid, S. Naik, Compartmentalized and systemic control of tissue immunity by commensals. Nat. Immunol. Jul. 14(7), 646\u2013653 (2013). https:\/\/doi.org\/10.1038\/ni.2604","journal-title":"Nat. Immunol. Jul"},{"key":"1103_CR274","doi-asserted-by":"publisher","first-page":"1091825","DOI":"10.3389\/fcimb.2023.1091825","volume":"13","author":"B Ni","year":"2023","unstructured":"B. Ni, X. Kong, Y. Yan, B. Fu, F. Zhou, S. Xu, Combined analysis of gut Microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer. Front. Cell. Infect. Microbiol. 13, 1091825 (2023). https:\/\/doi.org\/10.3389\/fcimb.2023.1091825","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1103_CR275","doi-asserted-by":"publisher","first-page":"811279","DOI":"10.3389\/fonc.2022.811279","volume":"12","author":"K Qian","year":"2022","unstructured":"K. Qian, Y. Deng, W.S. Krimsky et al., Airway microbiota in patients with synchronous multiple primary lung cancer: the bacterial topography of the respiratory tract. Front. Oncol. 12, 811279 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.811279","journal-title":"Front. Oncol."},{"key":"1103_CR276","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.12659\/msm.915332","volume":"25","author":"K Wang","year":"2019","unstructured":"K. Wang, Y. Huang, Z. Zhang et al., A preliminary study of microbiota diversity in saliva and Bronchoalveolar lavage fluid from patients with primary bronchogenic carcinoma. Medical science monitor : international medical journal of experimental and clinical research. Apr 17. 25, 2819\u20132834 (2019). https:\/\/doi.org\/10.12659\/msm.915332","journal-title":"Apr 17"},{"issue":"11","key":"1103_CR277","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1158\/1055-9965.Epi-24-0661","volume":"1","author":"JJ Tsay","year":"2024","unstructured":"J.J. Tsay, F. Darawshy, C. Wang et al., Lung microbial and host genomic signatures as predictors of prognosis in Early-Stage adenocarcinoma. cancer epidemiology, biomarkers & prevention : a publication of the American association for cancer research, cosponsored by the American society of preventive oncology. Nov. 1(11), 1433\u20131444 (2024). https:\/\/doi.org\/10.1158\/1055-9965.Epi-24-0661","journal-title":"Nov"},{"key":"1103_CR278","doi-asserted-by":"publisher","unstructured":"Q. Mao, W. Ma, Z. Wang et al., Differential flora in the microenvironment of lung tumor and paired adjacent normal tissues. Carcinogenesis. 41(8):1094\u20131103 (Aug 12. 2020). https:\/\/doi.org\/10.1093\/carcin\/bgaa044","DOI":"10.1093\/carcin\/bgaa044"},{"issue":"1","key":"1103_CR279","doi-asserted-by":"publisher","first-page":"103638","DOI":"10.1016\/j.isci.2021.103638","volume":"21","author":"H Dong","year":"2022","unstructured":"H. Dong, Q. Tan, Y. Xu et al., Convergent alteration of lung tissue microbiota and tumor cells in lung cancer. iScience Jan. 21(1), 103638 (2022). https:\/\/doi.org\/10.1016\/j.isci.2021.103638","journal-title":"iScience Jan"},{"issue":"1","key":"1103_CR280","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1002\/ctm2.70156","volume":"15","author":"F Mao","year":"2025","unstructured":"F. Mao, Z. Hu, R. Shi et al., Unravelling the prognostic and operative role of intratumoural microbiota in non-small cell lung cancer: insights from 16S rRNA and RNA sequencing. Clinical and translational medicine. Jan. 15(1), e70156 (2025). https:\/\/doi.org\/10.1002\/ctm2.70156","journal-title":"Jan"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01103-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01103-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:45:28Z","timestamp":1760525128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01103-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":280,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01103-3","relation":{"references":[{"id-type":"doi","id":"10.1126\/science.aad3369IF:","asserted-by":"subject"}]},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors read and approved the final version of the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}